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Vitamin D is thought to modulate both innate and adaptive immune responses 
at the cellular level, but the relationship between vitamin D, infection, and 
inflammatory processes across pregnancy is unclear. 
The first objective of this study was to describe the prevalence of clinically 
diagnosed infections and to identify risk factors for infections. The second objective 
was to examine associations between vitamin D status, systemic inflammatory 
biomarkers, and infections across pregnancy. The third objective was to evaluate 
associations between vitamin D and placental antimicrobial peptide expression. 
To address these study aims, the prevalence of clinically-diagnosed maternal 
infections and placental inflammation was determined and potential risk factors were 
identified. We determined that African-American race, higher pre-pregnancy body-
mass-index (BMI), younger age at diagnosis, and low intake of fat-soluble vitamins A 
and D were associated with greater infection prevalence. Using archived serum 
samples, we found positive associations between serum 1,25-dihydroxyvitamin D 
(1,25(OH)2D) and the pro-inflammatory cytokines IL-6 and TNF-α during pregnancy, 
but inverse associations were observed between 1,25(OH)2D and both pro-
 inflammatory cytokines at delivery. In addition, lower serum 25-hydroxyvitamin D 
25(OH)D status was associated with positive diagnosis of candida and bacterial 
vaginosis infections in these pregnant adolescents. In archived placental tissue 
samples, we found that the placental expression of vitamin D proteins (cubilin and 
CYP27B1) mediated the relationship between placental antimicrobial peptide 
expression and positive diagnosis of recto-vaginal group B streptococcus colonization 
in the mother. In summary, our results suggest that pregnant African American 
adolescents are at an increased risk for having sexually-transmitted and other vaginal 
infections during pregnancy, lower vitamin D status may increase risk of vaginal 
infections during pregnancy, and that vitamin D metabolites are associated with 
biomarkers of systemic inflammation and with the placental expression of 
antimicrobial peptides. Future research is needed to evaluate the potential for vitamin 
D supplementation to prevent and/or treat urogenital infections across gestation. 
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INTRODUCTION 
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Specific Aims 
Vitamin D insufficiency (25(OH)D <20 ng/mL) is a major public health 
concern for those who are unable to synthesize enough vitamin D from sun exposure 
and those who do not meet the dietary recommendations. Health disparities exist 
among pregnant adolescents and minorities with both groups being particularly 
vulnerable to D insufficiency, sexually-transmitted infections (STIs), and preterm birth 
(<37 weeks). In addition to its role in bone development, vitamin D has been linked to 
numerous immunological functions and disease-states. Currently, insufficient 
information is available on the bioactive nutrient, vitamin D, in relation to 
inflammatory processes and maternal/neonatal health outcomes. Recent data on the 
mechanisms through which vitamin D impacts inflammatory and immune mediators at 
the cellular-level (macrophages, dendritic cells, T cells, and B cells) provides 
biological plausibility for the associations which this study seeks to elucidate in group 
of pregnant adolescents (n=158, 13-18 years old) who completed a prospective study 
on adolescent pregnancy and fetal bone health. Therefore, there is a need to better 
understand the non-classical functions of vitamin D in preventing adverse health 
outcomes in high-risk populations like pregnant adolescents. To further our 
understanding of the relationship between vitamin D, infection, and inflammation 
during pregnancy, this research project addressed three goals: 1) To determine the 
prevalence of diagnosed infections across pregnancy and identify potential risk factors 
of infections; 2) To explore the relationship between systemic inflammatory 
biomarkers, vitamin D status, and infections; and 3) To elucidate factors associated 
with placental antimicrobial peptide expression and determine the impact of vitamin D 
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on its expression. 
 
The specific aims and hypotheses are:  
I: To assess the prevalence of maternal and placental infections and assess 
modifiable and non-modifiable risk factors that may be associated with these 
conditions.  
Hypothesis: Inadequate dietary intake, lower socio-economic status, and poor 
health behaviors will be associated with increased odds of having clinically 
diagnosed infections across pregnancy.  
 
II: To evaluate relationships between biomarkers of inflammation and vitamin D 
status measured across pregnancy and to identify associations between vitamin D 
status and clinically diagnosed infections in a group of racially and ethnically 
diverse pregnant adolescents. 
Hypotheses: 1) Maternal vitamin D inadequacy (25(OH)D < 20 ng/ml) will be 
associated with increased infection prevalence and an increased concentration 
of pro-inflammatory biomarkers in the mother. 2) Cord pro-inflammatory 
cytokine concentrations will be positively correlated with maternal 
inflammatory biomarkers and placental infections and inversely associated 
with cord vitamin D sufficiency (25(OH)D ≥ 20 ng/ml). 
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III: To elucidate factors associated with placental antimicrobial peptide (AMP) 
expression and to evaluate the degree to which vitamin D has an impact on 
placental AMP expression. 
Hypothesis: Placental cathelicidin (CAMP) (transcript and protein) and 
hepcidin (HAMP) (transcript) will be positively associated with maternal 
vitamin D sufficiency (25(OH)D ≥ 20 ng/ml). 
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Adolescent Sexual and Reproductive Health 
Improving the sexual and reproductive health of adolescents is a major public health 
priority. Sexual and reproductive health outcomes for this population are known to be greatly 
influenced by several factors, including age of onset for sexual activity, biological maturity, 
contraception use, and the burden of sexually transmitted infections.(1) In the U.S., 47% of high 
school students (9th-12th grade) have reported engaging in sexual activity at least once, with a 
higher prevalence among African Americans and Hispanics.(2) Younger adolescents who engage 
in sexual intercourse are less likely to use contraceptives (3) which puts them at greater risk of 
becoming pregnant or contracting a sexually transmitted infection (STI). Other risk-taking 
behaviors, such as illicit drug and alcohol use, are known to steadily increase across the ages of 
12-17 years.(4) This trend may pose a significant public health problem as a study in U.S. 
adolescents has found associations between substance abuse and increased self-report of risky 
sexual behaviors.(5) 
Despite the decline in teen births in the US over the past 20 years (6), the teen pregnancy 
rate remains the highest among developed countries (57 pregnancies per 1,000 females ages 15-
19 y) (7). Racial and ethnic disparities exist with Hispanic and African-Americans comprising 
the majority of the pregnant adolescent population (8). Pregnant teens are more at risk for 
adverse birth outcomes, such as low birth weight (< 2500 g), preterm birth (< 37 weeks), and 
neonatal mortality (9).  
Pregnant adolescents are faced with a unique nutritional challenge (10). Pregnancy is a 
state of increased nutrient demands, and because nutrient demands are higher to support the 
growing adolescent, there may be competition for nutrients between the mother and fetus (10). 
Using the dietary reference intakes (DRIs), research has shown that nutrient intakes for pregnant 
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adolescents typically fall below the recommended levels for iron, calcium, vitamin E, 
magnesium, and vitamin D (10, 11). Adequate nutrition is not only necessary to support normal 
growth and development, but also to maintain an optimal immune response (12).  
  
Infections during Pregnancy 
 During pregnancy, the amniotic cavity has traditionally been thought to be sterile (13). 
However, new data demonstrate that bacteria are capable of entering the amniotic fluid via 
several mechanisms: 1) ascension from the vagina to the cervix, 2) accidental needle 
contamination during amniocentesis or chorionic-villus sampling 3) blood traveling through the 
placenta (referred to as hematogenous infection), or 4) migrating through the fallopian tubes to 
the abdominal cavity (14). In addition to the amniotic fluid, there are several other potential sites 
for bacterial infections within the uterus, such as between maternal and fetal membranes 
(choriodecidual infection), within fetal membranes (chorioamnionitis), or the umbilical cord 
(funisitis) (14). Intra-amniotic infections can lead to severe consequences for fetus, such as a 
bloodstream infection known as sepsis (15). Intrauterine infections account for about 40% of 
preterm births (< 37 weeks) (16). Preterm birth occurs in about 11.4% of the U.S. pregnant 
female population (17) and is one of the leading causes of infant mortality in the U.S. (18). The 
underlying mechanisms responsible for the association between maternal infections and preterm 
birth are not well understood, but the activation of inflammation mediators (i.e. cytokines) 
(Figure 1.1) in response to microbial invasion has been hypothesized as one possible explanation 
(13, 14).  
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Figure 1.1: Pathogenesis of Chorioamnionitis: Maternal and Fetal Response and Complications1  
 
Figure source: Tita ATN, Andrews WW. Diagnosis and Management of Clinical 
Chorioamnionitis. Clinics in Perinatology 2010;37(2):339-354.(15) 
1IL=Interleukin, TNF=Tumor Necrosis Factor, MMP=Matrix metalloproteinase, FIRS=Fetal 
Inflammatory Response Syndrome, PTB Preterm birth 
 
Women are usually screened for urinary tract infections (UTIs) early in pregnancy (19). 
UTIs can either be classified as asymptomatic bacteriuria (ASB) or symptomatic (acute cystitis 
or acute pyelonephritis) (20). A variety of bacteria (Escherichia coli, Klebsiella pneumoniae, 
Staphylococcus aureus, and group B streptococci) can cause UTIs (20). Due to the physiological 
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changes associated with pregnancy, the ascension of bacteria during UTIs and subsequent 
development of a kidney infection (pyelonephritis) is a major concern (20).  
Bacterial and yeast infections commonly occur during pregnancy. Bacterial vaginosis 
(BV) and candida are two of the most common types of vaginitis (21). The normal vaginal flora 
consists of bacteria and yeast but infection occurs when there is an overgrowth of either species. 
BV infection is of concern during pregnancy because of observational studies which link BV to 
preterm birth (22, 23).  
Maternal sexually-transmitted infections (STIs) are known to cause a number of 
complications in the neonate, including neurological disorders, eye and lung infections, and low 
birth weight (LBW < 2500 g) (24). Because of the potential for maternal and neonatal 
complications to be associated with infections during pregnancy, the Center for Disease, Control, 
and Prevention (CDC) (Table 1.1) has established screening guidelines for several infections, 
especially STIs during pregnancy. 
 
Table 1.1: CDC Screening Guidelines for Infections during Pregnancy(24, 25) 
Infection CDC Recommendation 
Chlamydia First prenatal visit: Screen all pregnant 
women <25 years of age and also older 
pregnant women at increased risk for 
infection. 
Third trimester: Rescreen if <25 years of age 
or at continued high risk. 
 
Gonorrhea 
 
 
 
 
 
 
First prenatal visit: Screen all pregnant 
women <25 years of age in addition to older 
pregnant women who are at increased risk for 
infection. 
Third trimester: Rescreen women at 
continued high risk. 
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Table 1.1 cont’d 
 
Syphilis 
 
First prenatal visit: Screen all pregnant 
women. 
Early third trimester: Re-screen women who 
are high risk. 
 
Human Immunodeficiency virus (HIV) First prenatal visit: Screen all pregnant 
women. 
Third trimester: Rescreen women at high 
risk for acquiring HIV infection. 
 
Hepatitis B (HBV) First prenatal visit: Screen all pregnant 
women. 
Third trimester: Test those who were not 
screened prenatally, those who engage in 
behaviors that put them at high risk for 
infection, and those with signs or symptoms 
of hepatitis at the time of admission to the 
hospital for delivery. 
 
Hepatitis C (HCV) First prenatal visit: Screen all pregnant 
women at increased risk. 
 
 
Human Papillomavirus (HPV) 
 
There are no screening recommendations. 
 
Herpes (HSV) Evidence does not support routine HSV-2 
serologic testing among asymptomatic 
pregnant women. 
 
Bacterial Vaginosis (BV) 
 
Evidence does not support routine screening 
in asymptomatic pregnant women at high or 
low risk for preterm delivery. 
 
Trichomoniasis Evidence does not support routine screening 
for in asymptomatic pregnant women. 
 
Table adapted from CDC. STDs during Pregnancy - CDC Fact Sheet. 
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Pregnancy is considered a state of altered immunology with T lymphocyte (cell) and 
natural killer cell activity being reduced, while phagocytic activity and the number of dendritic 
cells, neutrophils, monocytes, and regulatory T cells  being maintained or enhanced (26). These 
immunological changes might explain why infection susceptibility and severity increase across 
pregnancy (26). Vitamin D is not only capable of promoting bone health but it’s also known to 
play a role in modulating the innate and adaptive immune response to infection. Despite these 
findings, limited data exist on risk factors for infection in adolescent pregnant populations and 
the role of vitamin D in regulating immunological activity in response to various infections 
occurring during pregnancy.  
 
Sources of Vitamin D  
Vitamin D is a unique, bioactive nutrient which can be produced in the skin (as vitamin 
D3) from 7-dehydrocholesterol following exposure to UVB light. The photo-isomerization of 
pre-vitamin D3 is followed by thermal isomerization into vitamin D3 (27). The dermal synthesis 
of vitamin D is affected by the season of the year. In periods of high sun exposure in the 
summer, the UVB radiation is of greater intensity. However, those living at northern latitudes 
(above 42 degrees) receive much lower UVB exposure during the winter season (28) and do not 
receive sufficient UVB exposure for vitamin D synthesis. Individual factors associated with 
reduced vitamin D synthesis include older age, sunscreen use, and darkly pigmented skin (29). In 
addition to endogenous production, vitamin D can also be consumed in the diet from plant 
sources as vitamin D2 (ergocalciferol), from animal sources as vitamin D3 (cholecalciferol) or 
from dietary supplements (either as D2 or D3). Few naturally occurring sources of dietary vitamin 
D are available, and these include fatty fish, egg yolk, and fish liver oil (29). Fortification of 
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foods (such as milk and breakfast cereals) provides the major source of vitamin D found in in the 
US diet (30). Dietary vitamin D supplements usually contain a dose of 400 IU/day, but 
supplemental D content has been increasing over the years. Based on a recent review published 
by the Institute of Medicine (IOM), in the US, supplemental vitamin D can be ingested in multi-
vitamin/multi-mineral formulations or as a single supplement with up to 5,000 IU of vitamin D3 
per dose or 50,000 IU of vitamin D2 per dose (with a prescription) (29). 
 
Vitamin D Metabolism and Homeostasis 
Vitamin D is a fat-soluble nutrient which is absorbed with other dietary fats in the small 
intestine (31, 32) and it enters the small intestine either by passive diffusion or transport-
mediated uptake via the scavenger receptor class B type 1 (SR-B1) or NPLC1 (33). Following 
absorption, vitamin D is packaged with cholesterol, triglycerides, and other lipids into 
chylomicrons (29) which transport this prohormone to the lymph, periphery, and finally to the 
liver as chylomicron remnants (34). The 25-hydroxylation step is loosely regulated by the 
amount of baseline 25(OH)D circulating in the body (35). Vitamin D from endogenous synthesis 
or dietary intake is either hydroxylated by the 25-hydroxylase enzyme (CYP2R1) which converts 
it into the prohormone 25-hydroxyvitamin D (25(OH)D) in the liver or vitamin D can be stored 
in adipose tissue (34). The sequestration of vitamin D in adipose tissue is associated with lower 
25(OH)D levels (36). Once 25(OH)D leaves the liver and enters the circulation, it is bound by 
the vitamin D-binding protein (DBP) (34). In the kidney and in other tissues, the uptake 
(endocytosis) of 25(OH)D bound to DBP is facilitated by the proteins megalin and cubilin (37, 
38). Once unbound from DBP, 25(OH)D is converted by the 1-α-hydroxylase (also known as 
CYP27B1) into its biologically active form 1,25-dihydroxyvitamin D (1,25(OH)2D) (also known 
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as calcitriol) (34) in the mitochondria. The prohormone 25(OH)D serves as the best biomarker of 
vitamin D status because it has a longer serum half-life than calcitriol (2-3 weeks vs. ~ 8 hours), 
it reflects both endogenously synthesized vitamin D and that obtained from dietary sources, its 
circulating concentration is 1000 times greater than calcitriol’s, and its production is not tightly 
regulated (39).  
The homeostatic mechanisms that control serum concentrations of calcitriol, calcium, and 
phosphate are important in bone development (Figure 1.2). Calcium and phosphate are very 
important components of bone, and calcium can be absorbed both passively and actively. Serum 
concentrations of calcium are tightly regulated by three hormones: calcitriol, parathyroid 
hormone (PTH), and calcitonin. Calcitriol can increase serum calcium concentrations in three 
ways. First, calcitriol acts directly on the small intestine to stimulate calcium absorption as well 
as phosphate absorption independently (29). With the help of the calcium sensing receptor in the 
parathyroid glands, low serum calcium leads to the production of PTH. Calcitriol production is 
increased by PTH to stimulate the secretion of the  receptor activator of nuclear factor kappa-
B ligand (RANK-L) which is necessary for osteoclast formation and subsequent bone resorption 
(29). Finally, PTH can act directly on the kidney to increase calcium reabsorption (40). Under 
states of high serum calcium, calcitonin functions to oppose the effects of PTH and promote the 
utilization of calcium by bone (29). 
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Figure 1.2: The Classical Effects of Vitamin D and Its Metabolic Pathways 
 
Figure source: Hewison, M., Vitamin D and immune function: an overview. Proc Nutr Soc, 
2012. 71(1): p. 50-61.(41)  
 
 
Phosphorus homeostasis was previously thought to only be regulated by the activity of 
PTH and calcitriol as side consequences of the regulation of calcium homeostasis, but beginning 
in 2000, fibroblast growth factor 23 (FGF23) was discovered as an additional hormone involved  
in phosphorus homeostasis (42, 43). PTH and FGF23 are not only involved in the maintenance 
of calcium and phosphorus homeostasis (29) but also in regulating calcitriol production. PTH 
and FGF23 (44) are known to induce and inhibit CYP27B1 activity, respectively (Figure 1.3). 
The 24-hyroxylase enzyme (also known as CYP24A1) regulates the catabolism of both calcitriol 
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and 25(OH)D into inactive metabolites in the kidney (35). The CYP24A1 enzyme can be 
induced by FGF23 and inhibited by PTH (45). Recently, there has been an increase in research 
addressing CYP24A1 expression as it has been suggested that elevated or abnormally long-
lasting expression of this enzyme may underlie diseases which would normally be responsive to 
treatment with vitamin D, such as FGF23-dependent renal phosphate wasting disorders (46). 
 
Figure 1.3: FGF23 and PTH Maintain Phosphate Homeostasis  
 
Figure source: Torres, P.A. and D.P. De Brauwere, Three feedback loops precisely regulating 
serum phosphate concentration. Kidney Int, 2011. 80(5): p. 443-5.(47)  
 
Calcitriol acts by binding to the vitamin D receptor (VDR), which heterodimerizes with 
retinoid-X receptor (RXR) to activate approximately 3% of the human genome for genes that 
contain vitamin D response elements (VDREs) (48). Under conditions of elevated calcitriol, 
CYP24A1 is up-regulated through the VDRE (35) and CYP27B1 is down-regulated through a 
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VDRE (49). Vitamin D metabolism can also be affected by genetic polymorphisms in VDR (50, 
51), CYP27B1, CYP24A1 (52, 53), DBP (54), CYP2R1 (55) and 7-dehydrocholesterol reductase 
(DHCR7) (56). 
Because various immune cells (T cells, B cells, NK cells, and monocytes) contain the 
VDR, vitamin D is thought to regulate their function (57). Inadequate vitamin D status has been 
associated with a variety of acute and chronic diseases, such as acute respiratory tract infections 
(58), urinary tract infections (59), rheumatoid arthritis (60), type I diabetes (61), cancer (62), 
multiple sclerosis (63), and systemic lupus erythematosus (64). However, limited data from 
randomized controlled trials are available and observational data on the relationship between vitamin D 
and extra-skeletal  diseases are inconsistent and inconclusive (65).  
It is well known that the active form of vitamin D, calcitriol, plays an important role in 
maintaining calcium and phosphate homeostasis and regulating bone metabolism. Severe vitamin 
deficiency may result in conditions characterized by inadequate bone mineralization in children 
(rickets) and adults (osteomalacia) (34).Therefore, the dietary requirements for vitamin D 
established by the Institute of Medicine (IOM) in 2011 were developed based solely on the 
nutrient’s role in promoting bone health. These recommendations reflect the amount of dietary 
vitamin D needed to achieve adequate 25(OH)D serum concentrations assuming minimal sun 
exposure (Table 1.2). An Estimated Average Requirement (EAR) and Recommended Dietary 
Allowance (RDA) have been established for all age groups except for infants 0-12 months old 
(29). Due to limited data on the infant population, an Adequate Intake (AI) of 400 IU for this age 
group has been defined in place of an EAR (29). 
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Table 1.2: Institute of Medicine Serum 25(OH)D cutoffs (29) 
“At risk of deficiency” “At risk for inadequacy” “Sufficiency” “There may be a 
reason for concern” 
25(OH)D < 12 ng/ml 
(30 nmol/L)  
25(OH)D 12 to  20 ng/ml 
(30-50 nmol/L)  
25(OH)D ≥ 20 ng/ml 
(50 nmol/L) 
25(OH)D >50 ng/ml 
(125 nmol/L)  
 
Vitamin D during Pregnancy 
During pregnancy, maternal ionized serum calcium concentrations remain constant but 
total calcium concentrations drop slightly during starting in early pregnancy (66). The regulation 
of PTH during pregnancy remains controversial. Some research has suggested that PTH 
decreases in pregnancy except among populations in Asia or Gambia with lower calcium intake 
(66). However, recent studies conducted in U.S. pregnant women (N= 350) and adolescents 
(N=168) ingesting high calcium intakes between 900 - 1,000 mg/d have shown that PTH 
increases during pregnancy in up to 25% of women, particularly in those with limited calcium 
intakes and low vitamin D status (67, 68). Because intestinal calcium absorption doubles in the 
mother during pregnancy, it is thought to be the main mechanism used to meet fetal calcium 
demands (66). Due to increases in calcium absorption and calcitonin during pregnancy, renal 
calcium excretion increases during pregnancy which may lead to hypercalciuria (66).  
Recently, researchers have found that during pregnancy, vitamin D is also essential for 
fetal skeletal development (69-71). In addition, vitamin D may have other roles in fetal 
developmental programming in utero for diseases later in life such as allergies (72) and 
cardiovascular disease (73) which are areas of growing research interest. 
During pregnancy, there are several additional factors to consider in vitamin D 
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metabolism and maternal and fetal vitamin D kinetics. First, the fetus is unable to synthesize 
vitamin D and must rely solely on the maternal supply of 25(OH)D which readily crosses the 
placenta (74, 75). Because calcitriol does not readily cross the placenta (76, 77), and fetal PTH 
concentrations are low (67), cord concentrations of calcitriol tend to be lower than those 
measured in maternal serum (74, 77). In addition to low PTH concentrations, high serum 
phosphorus and calcium concentrations also contribute to lower fetal calcitriol concentrations as 
these factors suppress renal CYP27B1 expression in the fetus (29). The mother and the fetus are 
able to independently synthesize the active metabolite of vitamin D from 25(OH)D. Recent 
research has indicated that the placental expression of megalin and cubilin increases across 
gestation and that these receptors may be involved in the placental transfer of 25(OH)D at this 
maternal-fetal interface (78). Second, serum calcitriol concentrations are elevated during 
pregnancy (79). Total calcitriol concentrations are known to double or triple during early 
pregnancy while 25(OH)D concentrations remain constant (80). The rationale for why serum 
calcitriol concentrations are not tightly regulated during pregnancy compared to during non-
pregnant state is unknown. 
Over 30 years ago the placenta was identified as a major extra-renal site for vitamin D 
metabolism as the placenta can convert the pro-hormone 25(OH)D into calcitriol (81, 82). The 
placenta expresses all of the enzymes necessary for vitamin D metabolism and regulatory 
function: CYP27B1, CYP24A1 and the VDR. Vitamin D is thought to regulate hormones 
involved in the maintenance of pregnancy and placental physiology with studies demonstrating 
an effect of 1,25(OH)2D on estradiol (83), human placental lactogen (hPL) (84), and human 
chorionic gonadotropin (hCG) (85). Some research suggests that the placental CYP24A1 gene is 
methylated and unresponsive to 1,25(OH)2D (86). Therefore, placental CYP27B1-mediated 
 18 
conversion in the absence of CYP24A1-mediated catabolism is thought to provide for 
unrestricted placental synthesis of 1,25(OH)2D during pregnancy (86). However, others have 
found significant associations between placental CYP24A1 and CYP27B1 expression (76), 
which suggest that CYP24A1 may not be silenced during pregnancy. Although the placenta is 
not thought to be the source of elevated maternal circulating concentrations of 1,25(OH)2D, a 
recent study has shown a significantly positive association between placental CYP27B1 mRNA 
expression and maternal 1,25(OH)2D at mid-gestation (76). Although the biological function of 
increased calcitriol during pregnancy is not yet known, researchers have proposed that placental 
calcitriol exhibits an autocrine/paracrine function (87) and this effect is immune-modulatory 
(88).  
Vitamin D insufficiency during pregnancy has been associated with adverse maternal and 
neonatal outcomes. Observational data suggests a relationship exists between low 25(OH)D 
concentrations and an elevated risk of preeclampsia (89), bacterial vaginosis (90), Cesarean 
section (C-section) (91), and babies born small-for-gestational age (SGA) (92). Recent studies 
have shown that oral vitamin D supplementation increases both 25(OH)D and 1,25(OH)2D 
during pregnancy (68, 93) and 25(OH)D ≥ 40 ng/ml is needed to support maximum systemic 
1,25(OH)2D production (68). However, improvements in maternal/fetal outcomes, such as pre-
eclampsia (93), gestational age at birth (68), or neonatal birth weight (68), as a direct result of 
supplementation remain inconclusive. Additional sufficiently powered RCTs in pregnant women 
are needed to further elucidate the findings between low serum 25(OH)D and adverse pregnancy 
outcomes evident in observational studies. 
Despite the potential impact of vitamin D on maternal and neonatal outcomes, the EAR 
(400 IU) and RDA (600 IU) for vitamin D do not differ between non-pregnant and pregnant 
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females. Data from National Health and Nutrition Examination Survey (NHANES) 2001-2006 
demonstrate that approximately 20% of U.S. pregnant women are not vitamin D sufficient 
(25(OH)D ≥ 20 ng/ml) (Table 1.3). A separate analysis of the NHANES data demonstrated that 
compared to pregnant Caucasian females (31 ng/ml), the mean 25(OH)D concentrations was 
almost 30% lower in pregnant Hispanic females (22 ng/ml) and approximately 50% lower in 
pregnant African-American females (16 ng/ml) (94).  
 
Table 1.3: Population Survey Data from Pregnant/Lactating or Reproductive-age women, U.S.(66)  
 
Group Mean 25(OH)D 
(ng/ml) 
Range 5th-95th percentile (ng/ml) 
Pregnant or lactating1 25 9.8-43.6 
Age 14-18 22.9 8.3-41.6 
Age 19-30 22.4 7.4-44.4 
Age 31-50 22.1 7.7-40.4 
Table adapted from Kovacs CS. The role of vitamin D in pregnancy and lactation: insights from 
animal models and clinical studies. Annu Rev Nutr 2012;32:97-123.  
Original data was obtained from the National Health and Nutrition Examination Survey. 
(NHANES) 2001-2006 using the Diasorin radioimmunoassay (RIA).  
1Among pregnant or lactating women (n=1,067), 72% had 25(OH)D ≥ 20 ng/ml, 21% 12-19 
nmol/L, and 7% < 12 ng/ml 
 
 
Adolescents are at high-risk for both vitamin D insufficiency (94) and sexually-
transmitted infections (95) and once they become pregnant, they are also at high risk for adverse 
birth outcomes (9). Therefore, the current vitamin D recommendations may not be adequate for 
minimizing adverse immunological or other non-bone health mediated effects during adolescent 
pregnancy which may be detrimental to the mother and/or the fetus (Tables 1.4-1.7), especially 
among high-risk populations such as pregnant minority adolescents. 
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Table 1.4: Summary of  Research on Vitamin D and Pre-eclampsia(89, 96, 97) 
Study Subject Characteristics  Results 
Bodnar et al. (2007)(89) 
(Observational- case-
control) 
 
N=274 
 
Serum 25(OH)D measured 
with a commercial ELISA 
from Immunodiagnostic 
Systems Limited (IDS, UK) 
and validated against a 
HPLC method. 
Pregnant women in 
America (14 - 44 y) at ≤ 
16 weeks gestation 
 Mean maternal serum 
25(OH)D was significantly 
lower in women who 
developed pre-eclampsia 
(P<0.01) 
 A 50 nmol/L decrease in 
serum 25(OH)D 
concentration doubled the 
likelihood of preeclampsia 
(OR: 2.4,  95% CI, 1.1–5.4) 
 
Bodnar et al. (2014)(96) 
(Observational- case-
cohort) 
 
N=3,703 
 
Serum 25(OH)D measured 
via liquid chromatography-
tandem mass spectrometry. 
 
 
Pregnant women in 
America (age range: 
N/A) with serum 
25(OH)D measured at ≤ 
26 weeks gestation. 
 
 
 Maternal serum 25(OH)D ≥ 
50 nmol/L was associated 
with a 35% reduction in the 
risk of pre-eclampsia 
(adjusted RR: 0.65, 95% CI, 
0.43–0.98) compared to 
those with 25(OH)D< 50. 
 
 
Naghshineh et al. 
(2016)(97) 
 (RCT) 
 
N=140 
 
Treatment: 600 IU/d of 
vitamin D until parturition  
Control: placebo 
 
Pregnant women (mean 
age: 25 y) in Iran at < 16 
weeks gestation. 
 
 No significant difference in 
number of women diagnosed 
or in the severity of pre-
eclampsia between the 2 
study groups (P=0.09). 
Enzyme-linked immunoassay; ELISA, High Performance Liquid Chromatography; HPLC, Odds 
Ratio; OR, Confidence Interval, CI, Relative Risk; RR, Randomized Controlled Trial; RCT. 
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Table 1.5: Summary of Research on Vitamin D and Preterm Birth (< 37 weeks)(98, 99) 
Study Subject Characteristics  Results 
Bodnar et al. (2015)(98) 
(Observational- case-cohort) 
 
N=3,453 
 
Maternal serum 25(OH)D 
was measured using liquid 
chromatography–tandem 
mass spectrometry. 
 
Pregnant women in 
America (≥ 18 y) with 
prenatal serum samples 
obtained at ≤ 20 weeks 
gestation. 
 Preterm birth (PTB) incidence 
was significantly higher 
among those with serum 
25(OH)D < 50 nmol/L 
(11.3%) compared to those 
with 25(OH)D 50-74.9 
nmol/L (8.6%) or  25(OH)D ≥ 
75 nmol/L (7.3%) (P<0.01). 
Wagner et al. (2016)(99)  
(Post-hoc analysis of two 
combined vitamin D RCTs) 
 
N=509 
 
Maternal serum 25(OH)D 
was measured using a rapid, 
direct radioimmunoassay 
(RIA) (Diasorin, USA). 
 
Treatment: study 1: 400 
IU/d, 2000 IU/d, or 4,000 
IU/d of vitamin D 
(68) or  
study 2: 2,000 IU/d vs 
4,000 IU/d of vitamin D(100). 
Pregnant women in 
America (17 – 44 y) 
between 12 to 16 weeks 
gestation. 
 
 
 Maternal serum 25(OH)D ≥ 
40 ng/ml was associated with 
a 57% lower risk of preterm 
birth when compared to those  
with 25(OH)D ≤ 20 ng/ml 
(RR: 0.43, 95% CI, 0.22-
0.83). 
 A fitted curve showed that 
gestational age at birth rose 
steadily with increasing 
25(OH)D concentrations and 
then plateaued at  40 ng/ml. 
Preterm birth; PTB, Randomized Controlled Trial; RCT, Relative Risk; RR, Confidence Interval, 
CI. 
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Table 1.6: Summary of Research On Vitamin D and Gestational Diabetes(101-104) 
Study Subject Characteristics Results 
Burris et al. (2012)(101) 
(Observational- prospective 
cohort study) 
 
N=1,314 
 
Maternal serum 25(OH)D 
was measured with both an 
automated 
chemiluminescence 
immunoassay (CLIA) a 
manual radioimmunoassay 
(RIA). 
 
Pregnant women in 
America (mean age: 32 y) 
at < 22 weeks gestation. 
 Maternal serum 25(OH)D 
concentration <25 nmol/L was 
associated with higher odds of 
gestational diabetes when 
compared to those with 
25(OH)D ≥ 25 nmol/L (OR: 
2.2, 95% CI, 0.8- 5.5). 
Clifton-Bligh et al. 
(2008)(102) 
(Observational- prospective 
cohort study) 
 
N=264 
 
Maternal serum 25(OH)D 
was measured with the 
Nichols Advantage assay 
(Nichols Institute 
Diagnostics, USA 
 
Pregnant women in 
Australia (mean age: 33 y) 
with blood sampling 
conducted at a mean of 29 
weeks gestation. 
 Maternal serum 25(OH)D 
concentration was significantly 
lower in those with gestational 
diabetes (48.6 ± 24.9 nmol/L)  
vs. those without 
(55.3 ± 23.3 nmol/L) (P=0.04). 
 
Farrant et al. (2009)(103) 
(Observational- prospective 
cohort study) 
 
N=559 
 
Maternal 25(OH)D was 
measured using a 
radioimmunoassay (RIA) 
Immunodiag. Ltd, UK 
 
 
 
 
Pregnant women in India 
(mean age: 24 y) at < 32 
weeks gestation. 
 No statistically significant 
associations between maternal 
serum 25(OH)D concentrations 
and incidence of gestational 
diabetes were evident (P=0.8). 
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Table 1.6 cont’d 
 
Makgoba et al. (2011)(104) 
(Observational- case-control 
study) 
 
N=248 
 
Maternal 25(OH)D was 
measured by liquid 
chromatography-tandem 
mass spectrometry. 
 
 
Pregnant women in the 
United Kingdom (mean 
age: 33 y) with first 
trimester blood samples 
 
 
 Baseline maternal serum 
25(OH)D concentrations were 
not significantly different 
between those who later 
developed gestational diabetes 
and those who did not 
(P=0.9). 
Odds Ratio; OR, Confidence Interval; CI. 
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Table 1.7: Summary of Research on Vitamin D and Cesarean Section(91, 105, 106) 
Study Subject Characteristics  Results 
Merewood et al. (2009)(91) 
 
N=253 
 
(Observational- cross-
sectional study) 
Maternal 25(OH)D was 
measured with a 
competitive protein binding 
assay. 
 
Pregnant women in 
America (mean age: 26 y) 
within 72 hours of giving 
birth. 
 Women with maternal serum 
25(OH)D < 37.5 nmol/L 
were almost 4 times as likely 
to have a cesarean section 
compared to with 25(OH)D 
≥ 37.5 nmol/L (OR: 3.84, 
95% CI, 1.71-8.62). 
 
Gernand et al. (2015)(105) 
 
N=2,798 
 
(Observational- 
retrospective  
cohort study) 
Maternal 25(OH)D was 
measured by liquid 
chromatography-tandem 
mass spectrometry. 
 
Pregnant women in 
America (mean age: N/A) 
with serum samples  
obtained at ≤ 26 weeks 
gestation. 
 No statistically significant 
associations between 
maternal serum 25(OH)D 
concentrations and cesarean 
section were evident.  
Scholl et al. (2012)(106) 
 
N=1,153 
 
(Observational- prospective 
cohort study) 
Maternal 25(OH)D was 
measured by HPLC 
(Chromosorb, Germany). 
Pregnant minority women 
in America (mean age: 23 
y) with serum samples 
collected at entry into 
prenatal care (mean: ~14 
weeks gestation). 
 Maternal serum 25(OH)D < 
37.5 nmol/L was associated 
with almost 2 times greater 
odds of cesarean delivery 
compared to those with 
25(OH)D ≥ 80 nmol/L 
(AOR: 1.74, 95% CI, 1.13-
2.67). 
Odds Ratio; OR, Confidence Interval; CI, High Performance Liquid Chromatography; HPLC, 
Adjusted Odds Ratio; AOR. 
 
 
Vitamin D and Innate Immunity 
Innate immunity is a non-specific response and the first line of defense against invading 
microorganisms (107).This process involves biochemical and cellular defense mechanisms 
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which are already in place long before an infection occurs; thus, the response is rapid (107) . The 
major components of innate immunity are epithelial barriers and antimicrobial substances, 
cytokines, blood proteins involved in the complement system, phagocytic cells (neutrophils and 
macrophages) and natural killer (NK) cells (107).The activation of transmembrane toll-like 
receptors (TLRs) in monocytes, macrophages, dendritic cells as well as in several epithelial cells 
(i.e. intestine, bladder, and vagina) is a critical step in microbial pattern recognition and 
subsequent innate immune response (107). Once activated, TLRs induce antimicrobial peptides 
and reactive oxygen species to destroy the microorganism (108). 
Antimicrobial peptides (AMPs) are usually small, amphipathic proteins found on almost 
all body surfaces and in every tissue (107) . AMPs such as human cathelicidin and β-defensins 
are known to kill a broad range of pathogens, including gram-positive and gram-negative 
bacteria, fungi, and viruses (109). The antimicrobial action of vitamin D is thought to be 
mediated through an intracrine cellular response to microbial stimulation (41). Liu and 
colleagues have demonstrated that bacteria and their surface-associated molecules can induce the 
expression of CYP27B1 and VDR mRNA in human macrophages in vitro (110) and in human 
monocytes ex vivo (111). The mechanism through which calcitriol regulates innate immunity is 
thought to be mediated by stimulation of cathelicidin production in TLR-activated monocytes 
and macrophages (111) (Figure 1.4). Because vitamin D response elements have been identified 
in the promoter regions of the genes encoding antimicrobial peptides such as cathelicidin and 
human β-defensin-2 (112), it has been suggested that vitamin D plays a role in regulating their 
expression. Furthermore, in response to Mycobacterium bovis, cathelicidin has been shown to 
co-localize with bacteria-containing vacuoles in monocytes treated with calcitriol but not in those 
without treatment (110).  
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Figure 1.4: Regulation of Innate Immunity by 1,25(OH)2D
1 
 
 
Figure Source: Bikle DD. Vitamin D: newly discovered actions require 
reconsideration of physiologic requirements. Trends in Endocrinology and 
Metabolism 2010; 21(6):375-384.(108) 
1Yellow arrows demonstrate TLR stimulation of CYP27B1 and cathelicidin 
(independently) and the metabolism of 25(OH)D into 1,25(OH)2D. Green arrows 
indicate upregulation of VDR by 1,25(OH)2D and subsequent induction of 
cathelicidin. 
 
Numerous in vitro studies have shown that calcitriol increases the production of the 
antimicrobial peptides cathelicidin (110, 113, 114) and β-defensin-2 by binding to the VDR in 
macrophages (113, 114), one of the first cells to recognize and engulf foreign substances during 
infections. In vitro studies have also shown that low concentrations of 25(OH)D were associated 
with reduced production of cathelicidin by human macrophages in response to Mycobacterium 
tuberculosis (110). Serum 25(OH)D concentrations have been shown to be consistently lower in 
African-Americans when compared to Caucasians (110, 115), ex vivo supplementation of 
African-American sera with 25(OH)D to physiological concentrations (1-100 nM) has been 
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shown to restore cathelicidin production (110). Similarly, in vivo supplementation (50,000 IU of 
vitamin D2) of elderly patients with 25(OH)D <30 ng/ml has been shown to significantly 
enhance monocyte production of cathelicidin in monocytes isolated from peripheral blood 
mononuclear cells (PBMCs) (111).  AMPs are known to be expressed in human trophoblasts 
(116, 117). However, the role of placental antimicrobial peptides and vitamin D in the prevention 
of localized infections during pregnancy remains unclear. 
Hepcidin is a well-recognized AMP which functions to limit extracellular microbial 
growth by preventing the release of intra-cellular iron, the most essential growth-limiting 
nutrient for potential pathogens (120) . The gene for hepcidin (HAMP) contains a VDRE (118). 
Recent research has shown that hepcidin is also responsive to calcitriol bound to the VDR (118). 
In this study, 25(OH)D and calcitriol administered to PBMC monocytes decreased hepcidin 
mRNA expression in vitro, and vitamin D supplementation (100,000 IU vitamin D2) led to a 
~30% decrease in circulating hepcidin levels in healthy adults (in vivo) within 24 hours (118). 
The opposing action of calcitriol on hepcidin may reflect a delicate balance during intracellular 
infections as iron plays a key role in promoting both host antimicrobial activity (as an essential 
co-factor for macrophages) and intracellular pathogen survival (119). Free or non-transferrin 
bound serum iron is important for extracellular microbial growth (120). However, it is not well 
understood how calcitriol might differentially regulate hepcidin in response to intracellular vs 
extracellular microbial stimuli.  
Research studies have indicated that microorganisms may escape the host defense by 
reducing AMP activity (121) and the effect of vitamin D in innate and adaptive immunity. M. 
tuberculosis, M. leprae, and human immunodeficiency virus (HIV) have been shown to inhibit 
VDR activity (122).  
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Cytokines play a role in both innate and adaptive immunity (107). During innate 
immunity, activated macrophages secrete cytokines which increase the permeability of blood 
vessels and chemokines which attract other immune cells, such as neutrophils (107). The 
accumulation of immune cells at the site of an infection can lead to tissue injury in a process 
known as inflammation (107). Numerous in vitro studies have shown that vitamin D inhibits pro-
inflammatory cytokine production (43, 123, 124) while increasing anti-inflammatory cytokines 
in human immune cells (125, 126). 
 
Vitamin D and Adaptive Immunity 
Adaptive (or “acquired”) immunity is a specific, adaptive response to an infection (107) . 
This process involves remembering a prior exposure and developing specificity for the unique 
microbial molecules; thus, the response to repeated exposures is more rapid (107) . Lymphocytes 
(T cells and B cells) and the products they secrete (e.g. antibodies) are the major components of 
adaptive immunity (107) . The initiation of adaptive immunity requires antigen-presenting cells 
(e.g. dendritic cells) to capture and “present” antigens to specific lymphocytes (107) . 
Vitamin D plays a role in regulating the antigen presentation process which is necessary 
to activate adaptive immunity. Both the VDR (127) and CYP27B1 enzyme (128) are expressed 
in dendritic cells (DCs). Studies have shown that 25(OH)D (in vitro) (128) and calcitriol (in vitro 
and in vivo) act to suppress DC maturation and function (128-130) with VDR and CYP27B1 
knockout mice displaying an increase in mature DCs (131, 132). Calcitriol is thought to function 
via a paracrine mechanism in DCs (41). Immunosuppression occurs as VDR-poor DCs produce 
calcitriol which acts on VDR-rich DCs to suppress their maturation and subsequent ability to 
activate T cells (41). 
 29 
Both T cells and B cells express the VDR (133, 134). In cell-mediated immunity, naive 
CD4+ T helper cells may differentiate into two types of cells: Th1 cells or Th2 cells (107). Th1 
cells are involved in promoting the inflammation response by producing pro-inflammatory 
cytokines which stimulate macrophage activation (e.g. INF-γ, TNF-α, IL-2) (107). During 
inflammation, IL-6 is capable of inducing both C-reactive protein (CRP) and hepcidin 
production in the liver. In contrast, Th2 cells are responsible for inhibiting macrophage 
activation by producing anti-inflammatory cytokines (e.g. IL-4, IL-5, and IL-13) (107). In T 
helper cells, calcitriol acts to inhibit Th1 cells in vitro (135) and enhance the production of Th2 
cell-associated cytokines in vitro (136, 137). It is not well-understood if the shift from Th1 to 
Th2 cells is present in vivo (41) as results on this topic are conflicting (138). Despite this, 
calcitriol is believed to function in maintaining a balance between inflammation and 
immunosuppression (41). Th17 cells are another class of lymphocytes which are responsible for 
promoting a pro-inflammatory cytokine (IL-17) response to microbial invasion (41), and they 
have been associated with inflammatory tissue damage (139, 140). In vitro studies have shown 
that calcitriol suppresses Th17 development (141, 142) and inhibits IL-17 production (28). 
Similarly, in vivo studies have demonstrated elevated IL-17 levels in CYP27B1 knockout mice 
(138). Additionally, calcitriol has been shown to induce the development of suppressor or 
regulatory T-cells (Tregs) leading to enhanced IL-10 production (143-145). The function of 
calcitriol in CD8+ T cells remains unclear (41). In B cells, calcitriol is believed to act in an 
autocrine/intracrine mechanism (41) as it is has been shown that B cells contain CYP27B1 (146), 
and calcitriol is capable of inhibiting B cell differentiation, proliferation, and immunoglobulin 
production (146). 
Because many pathogenic intracellular microorganisms have evolved to evade host 
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defense mechanisms, they can persist and cause chronic T cell and macrophage activation (107). 
The accumulation of immune cells (especially macrophages) at the site of an infection can lead 
to tissue injury: the formation of granulomas which are associated with necrosis (un-programmed 
cell and tissue death) and fibrosis (excess deposition of fibrous connective tissue/scarring) (107). 
To prevent the potentially adverse effects of persistent immune signaling, the function of vitamin 
D in adaptive immunity is thought to be immunosuppression (41) (Figure 1.5). 
 
Figure 1.5: Regulation of Adaptive Immunity by 1,25(OH)2D
1 
 
 
Figure Source: Bikle DD. Vitamin D: newly discovered actions require 
reconsideration of physiologic requirements. Trends in Endocrinology and 
Metabolism 2010;21(6):375-384.(108) 
1Yellow arrows demonstrate dendritic cell stimulation of CD4 cell differentiation 
into four types (Th1, Th17, Th2, and Treg) and the metabolism of 25(OH)D into 
1,25(OH)2D. Green arrows indicate promotion and red arrows indicate inhibition 
of cell differentiation by 1,25(OH)2D, respectively. 
  
Data on the regulation of inflammation during pregnancy are both limited and 
conflicting. Calcitriol has been shown to downregulate the mRNA expression of the pro-
inflammatory cytokines TNF-α and IL-6 in cultured placental cells from preeclamptic women 
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(87), and a recent RCT conducted in 57 US pregnant women found that 2000 IU of vitamin D 
supplementation was more effective in increasing IL-10+ regulatory CD4+ T cells than 
supplementation with 400 IU (147). In contrast to vitamin D’s well-known anti-inflammatory 
action, calcitriol has been shown to down-regulate the mRNA expression of anti-inflammatory 
cytokine IL-10 in cultured human trophoblasts under experimental conditions with or without 
inflammation (148).  
During pregnancy, Th2 cell induction is critical to promote a normal pregnancy (115). If 
the implantation of the fetus is not tolerated, an adverse Th1 pro-inflammatory cytokine response 
is thought to be initiated (149). Vitamin D is believed to play a role in the shift to a Th2 anti-
inflammatory immune response during pregnancy (115). Because microbial infection during 
pregnancy leads to the production of pro-inflammatory cytokines, research has suggested that the 
cascade of pro-inflammatory cytokines and prostaglandin production may play a role in the 
development of preterm birth (<37 weeks of gestational age) associated with maternal infections 
(150). Due to the established anti-inflammatory activity of calcitriol, it is important to understand 
the vital role vitamin D may play in regulating the immune response during infection and 
inflammatory states which arise throughout pregnancy. 
 
Parent Study 
Pregnant adolescents (n=158, aged ≤18 y) were recruited from the Rochester Adolescent 
Maternity Program (RAMP) clinic in Rochester, NY and longitudinally followed across 
pregnancy. An additional 10 adolescents were recruited from Baltimore but did not have 
inflammatory indicators measured thus the group studied in Rochester will be used for this 
research. The parent study was a study of maternal and fetal bone health and iron status across 
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gestation. The study recruitment period was undertaken between 2006 - 2009. Non-smoking 
adolescents between 12 and 30 weeks of gestation at entry were eligible to participate in the 
study if they were carrying a single fetus and did not have a preexisting medical complication 
(e.g. HIV infection, diabetes/gestational diabetes, elevated diastolic blood pressure (>110), 
pregnancy-induced hypertension, malabsorption diseases, or diagnosed eating disorders). Teens 
with a history of steroid use and/or substance abuse, those taking medications known to 
influence calcium or vitamin D homeostasis, and those identified as having elevated blood lead 
concentrations during childhood were excluded from the study. Adolescents were recruited in 
proportion to the racial and ethnic composition of the patient population (66.1% African 
American, 33.9% Caucasian, and 24.1% Hispanic). Informed consent was obtained from those 
that were willing to participate, and the study was approved by the Institutional Review Boards 
at the University of Rochester and Cornell University. Results on bone turnover and 
osteoprotegerin (151), maternal calcitropic hormones (67), fetal bone growth (152), maternal 
bone quality across gestation (153), placental vitamin D metabolic enzyme expression (76), 
placental VDR expression (71), expression of placental iron transporters (154, 155), maternal 
dietary intake (11), and maternal and neonatal iron status (156, 157) in this cohort have been 
published. 
At entry into the study, important health and demographic data were obtained using a 
health survey demographic questionnaire. Self-reported information on maternal race, ethnicity, 
age, pre-pregnancy weight, socioeconomic status etc. was collected by the health project 
coordinator (Appendix 1). During the study, each adolescent attended up to three prenatal visits 
at early, mid, and late gestation. At each visit, maternal anthropometrics (height, weight, etc.) 
were recorded by clinical staff using standard procedures. A 24-hour dietary recall and prenatal 
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supplement survey were collected at each visit by study personnel. The recalls were analyzed by 
a registered dietician using the Nutrition Data System for Research (NDSR: University of 
Minnesota, Minneapolis, MN, versions 2006, 2008, and 2009) in Rochester, NY.  Baby birth 
data was also collected (Appendix 2). 
As part of the retrospective study, 25 pre-defined infections and inflammatory conditions 
were abstracted from their prenatal medical records by the health project coordinator using a 
study tool (Appendix 3). Archived blood samples collected during pregnancy (~26 weeks 
gestation), at delivery, and in the neonate at birth were used to undertake new analyses of 
inflammatory biomarkers. In addition, archived placental tissue samples were used to conduct 
new studies on placental vitamin D protein and placental antimicrobial peptide expression 
(Figure 1.6). Informed written consent was obtained from all participants and in participants 14 
y of age and younger, both adolescent assent and parental consent were obtained (Appendix 4). 
The study was approved by the Institutional Review Boards at Cornell University and the 
University of Rochester. 
 
Figure 1.6: Parent Study Timeline 
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ABSTRACT  
Study Objective 
Our objective was to identify risk factors associated with maternal infections and placental 
inflammation in pregnant adolescents attending an urban adolescent maternity clinic.  
Design 
This cross-sectional, descriptive study used survey and medical chart data collected at entry and 
prospectively across gestation. The prevalence of maternal infections and placental inflammation 
was determined and potential risk factors were identified. 
Setting 
Rochester Adolescent Maternal Program (RAMP) in Rochester, NY 
Participants 
Racially and ethnically diverse pregnant adolescents (n=158 ≤ 18 y at entry) were recruited. 
Main Outcome Measures 
Main outcome measures were diagnosis of an infection or inflammatory condition in relation to 
demographic, anthropometric, dietary, socioeconomic, and health data. 
Results 
The three most prevalent infections diagnosed in this study population were recto-vaginal 
colonization of group B Streptococcus (GBS) (38%), bacterial vaginosis (BV) (40%) and 
candida (42%). African-American teens (AOR=4.6; 95% CI: 1.74-13.02) and those with higher 
pre-pregnancy BMI (ppBMI; AOR=1.2; 95% CI: 1.04-1.31) were more likely to test positive for 
BV across gestation. Older maternal age decreased the likelihood of positive tests for 
trichomoniasis (OR=0.51; 95% CI: 0.26-0.92) and gonorrhea (OR=0.38; 95% CI: 0.16-0.82). 
Higher mean dietary vitamin D intake (mcg/d) was associated with a lower likelihood of testing 
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positive for recto-vaginal GBS (OR=0.87; 95% CI: 0.77-0.98). 
Conclusions 
Addressing modifiable risk factors associated with dietary intake and pre-pregnancy weight may 
help reduce health disparities among pregnant minority adolescents. Additionally, targeted 
sexual health education may greatly benefit younger female adolescents. 
 
INTRODUCTION 
The U.S. teen pregnancy rate remains the highest among developed countries (57 
pregnancies per 1,000 females ages 15-19 years)(1) with Hispanic and African-American teens 
comprising the majority of this population.(2) Unplanned pregnancies pose significant 
challenges to reproductive health as they have been linked to risky sexual behaviors(3) and 
adverse infant health outcomes.(4) Compared to young adult women (aged 20-24 years), 
pregnant teens are more likely to be unmarried, have inadequate prenatal care, and not achieve 
recommended pregnancy weight gains. In addition, neonates born to teens are at greater risk for 
low Apgar scores, prematurity, and increased risk of neonatal mortality.(5)   
During pregnancy, sexually-transmitted, urogenital, and placental infections are of major 
concern. U.S. teens and young adults (15-24 years old) compromise 50% of new sexually-
transmitted infection (STI) cases each year.(6) Maternal infections during pregnancy and their 
transmission to the neonate during labor and delivery have been linked to adverse health 
outcomes, including premature birth,(7) low birth weight (LBW) (<2500 g),(8) and newborn 
lung and eye infections.(9) Therefore, the Centers for Disease Control and Prevention (CDC) 
recommends screening all pregnant females for chlamydia, hepatitis B, human 
immunodeficiency virus (HIV), and syphilis over the course of pregnancy and those deemed 
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high-risk should also be screened for gonorrhea and hepatitis C.(10) In addition, screening for 
recto-vaginal group B streptococcal colonization (GBS) is recommended for all pregnant women 
between 35-37 weeks of gestation.(10) In contrast, some infections such as bacterial vaginosis 
(BV) are not routinely screened for during pregnancy despite a growing body of research linking 
BV to undesirable birth outcomes.(11)   
Most of the research exploring infection risk factors has focused on adult populations and 
risk factors vary depending on the infection in question. Previously identified risk factors for BV 
include low socioeconomic status, race, smoking, higher body mass index (BMI), having a past 
pregnancy, and increased number of sexual partners.(12,13) Urinary tract infections are common 
during pregnancy, and the American College of Obstetrics and Gynecology (ACOG) 
recommends screening all pregnant women for asymptomatic bacteriuria during the first prenatal 
visit and third trimester.(14) Prior studies have reported several risk factors for urinary tract 
infections (UTIs) occurring over pregnancy, including pre-eclampsia, hypertension, low 
socioeconomic status, and anemia.(15) Younger age (16,17)  and the consumption of fruit juices 
and milk products containing probiotics has also been associated with a reduced risk of recurrent 
UTIs in non-pregnant adult women.(18)  
Much less is known about risk factors in other age groups and little is known about these 
relationships in pregnant adolescents, a population which is at increased risk for STIs and 
adverse neonatal outcomes. The primary objective of this study was to describe the prevalence 
of, and identify potential risk factors (health behaviors, demographic, socioeconomic, 
anthropometric, and dietary) for common infections across gestation in a racially and ethnically 
diverse group of pregnant adolescents (≤ 18 years of age).   
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MATERIALS AND METHODS 
Study Population 
A group of 158 pregnant adolescents (≤ 18 years old) were recruited from the Rochester 
Adolescent Maternity Program (RAMP) in Rochester, New York from 2006-2009 for a study 
designed to examine maternal and fetal bone health. Adolescents were recruited in proportion to 
the racial and ethnic composition of the patient population (65% African American, 35% 
Caucasian, and 25% Hispanic) (Table 2.1). 
 
Table 2.1: Subject Characteristics of the 158 Pregnant Adolecentsa 
aValues are presented as the mean ± SD or % (n); GA, Gestational age; WIC, Special 
Supplemental Nutrition Program for Women, Infants, and Children. 
 
All eligible adolescents were approached by the study coordinator, and the majority 
agreed to volunteer to participate in this research study. Participants were eligible for the study if 
they were between 12 and 30 weeks gestation at entry, carrying a single fetus, and at least 13 
years of age. Additional eligibility and exclusion criteria have been previously described.(19) 
  Characteristics  Value 
 Age at enrollment (years) 17.1 ± 1.1 (158) 
 Race, %  
                 African American   63.3 (100/158) 
                 Caucasian 35.4 (56/158) 
                 Native American                    1.3 (2/158) 
 Ethnicity, %  
                 Hispanic 24.7 (39/158) 
                 Non-Hispanic 75.3 (119/158) 
 GA at entry into prenatal care (wks) 10.5 ± 4.7 (137) 
 GA at delivery (wks) 39.2 ± 3.0 (152) 
 Pre-pregnancy BMI (ppBMI) (kg/m2) 24.7 ± 5.4 (156) 
                 Underweight (<18.5), %                                                                                                  6.4 (10/156) 
                 Normal (18.5-24.9), %     57 (89/156)                          
                 Overweight (≥ 25.0), %          19 (30/156) 
                 Obese (≥ 30.0), %                  17 (27/156) 
 WIC enrollment, % 72.6 (114/157) 
 Prior birth control use, %  16.5 (26/158) 
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Adolescents were longitudinally followed from study entry until delivery and medical chart data 
were abstracted from entry into prenatal care until delivery. Informed written consent was 
obtained from all participants after fully explaining the study and study procedures in accordance 
with the institutional guidelines. The study was approved by the Institutional Review Boards at 
Cornell University and the University of Rochester.  
Data Collection 
At study entry, key health and demographic data were obtained by the study health 
project coordinator as previously described.(19, 20) Socioeconomic status indicators assessed 
included health insurance, participation in the Special Supplemental Nutrition Program for 
Women, Infants, and Children (WIC), or welfare/public assistance programs. Self-reported risk 
taking behaviors (before and during pregnancy) were queried, including use of alcohol and 
cigarettes categorized as never used, prior use, or current use. Self-reported use of marijuana as 
well as “other drugs” (cocaine, stimulants, sedatives, and narcotics) were described as ever used 
versus never used before or during pregnancy. Birth control use (yes/no) prior to conception was 
ascertained. Pre-pregnancy body mass index (ppBMI) was calculated and categorized as 
underweight (<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (≥ 25.0 kg/m2), or 
obese (≥ 30.0 kg/m2) using self-reported height and weight following the World Health 
Organization guidelines.(21)   
Adolescents attended up to three prenatal study visits, at which time maternal 
anthropometrics and all survey instruments were completed. The mean micronutrient and 
macronutrient intakes were obtained using a 24-hour dietary recall and the estimated average 
requirement (EAR) and acceptable macronutrient distribution range (AMDR) were used to 
classify adequate vs. inadequate nutrient intake as previously described.(20) A prenatal 
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supplement survey was used to assess frequency of supplement as daily vs. not daily for analysis 
purposes. 
Data on 18 pre-defined infections and inflammatory conditions were abstracted from the 
participant’s prenatal medical records (STIs, UTIs, vaginal infections, placental inflammatory 
conditions, and other viral and bacterial infections) by our study health project coordinator. The 
prevalence of each condition was calculated and presented in Table 2.2. For each condition 
reported, the date of clinician diagnosis or date of laboratory results for the condition and 
prescribed treatments were recorded. Classifications used for conditions monitored were 
determined by obstetrics and gynecology clinicians and co-authors at the University of Rochester 
Medical Center (URMC).   
 
Table 2.2: Prevalence of Maternal Infection and Inflammatory Conditions Across Pregnancy in 
158 Pregnant Adolescents 
 
Sexually Transmitted Infections (STIs): 
Gonorrhea                           3% 
Chlamydia                         13% 
Syphilis                             0.6% 
Genital Warts                      4% 
Genital Herpes                    1% 
Trichomoniasis                    7% 
Human Papillomavirus      7.6% 
 
Urinary Tract  Infections (UTIs): 
Pyelonephritis                      1% 
Cystitis                               25% 
 
Vaginal Infections: 
Candida                              42% 
Bacterial Vaginosis            40% 
Placental Inflammation (n=45)a: 
Chorioamnionitis                14% 
Chronic Vilitis                    0.6% 
Deciduitis                             9% 
Acute Funisitis                    11% 
Other Infections: 
Hepatitis B                           0% 
Hepatitis C                        0.6% 
Other (Carrier State): 
Group B Strep                    38% 
aValues presented are only from a sub-sample of adolescents (N=45) whose placentas were sent 
to pathology for medically indicated purposes. 
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Statistical Analysis 
Potential determinants of infections and inflammatory conditions including: demographic 
factors (race, ethnicity, maternal age at time of infection diagnosis, age at menarche, 
gynecological age at conception), socioeconomic status (SES) (WIC participation, use of public 
assistance, and health insurance participation), anthropometric factors (ppBMI), dietary factors 
(micronutrient and macronutrient intake), and health behaviors (self-reported use of prenatal 
supplements and substance abuse behaviors) were assessed using chi-square test of independence 
for categorical variables and bivariate logistic regression for continuous variables. Fisher’s exact 
test was used when data in cross tabulations were sparse or unbalanced (n < 5). Outcomes of 
infection (positive/negative) and inflammation (presence/absence) were analyzed as categorical 
variables while potential risk factors were analyzed as either categorical or continuous variables. 
Multiple logistic regression was used to simultaneously assess the association of multiple risk 
factors on infection outcomes. Results were considered statistically significant at P<0.05. All 
analyses were performed using JMP 11.0 (SAS Institute).  
 
RESULTS 
In this study population, 73% (114/157) of teens were enrolled in WIC, 18% (22/121) used 
public assistance programs, and 91% (143/158) had some form of health insurance. Most of the 
teens 68% (108/158) reported that they had obtained at least a 10th grade or higher level of 
education. From among the indicators of socioeconomic status available, none were significantly 
associated with the outcomes of interest.  
Of the infections and inflammatory conditions presented in Table 2.2, 30.4% (48/158) of 
teens had at least one diagnosed STI, 25.3% (40/158) had one, 3.8% (6/158) had two, and 1.3% 
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(2/158) had three STIs across gestation. For the 64% (101/158) of teens found to have at least 
one vaginal infection, 45.6% (72/158) had one and 18.4% (29/158) had two recorded diagnoses 
across gestation. For teens that had their placentas sent to pathology at delivery due to medically 
indicated concerns, 60% (27/45) had pathologic evidence of placental inflammation. The odds of 
having a vaginal infection were 2.4 times higher in those with a STI (OR=2.4; 95% CI: 1.1-5.4) 
compared to teens who were not diagnosed with a STI during pregnancy. 
Significant associations between study outcomes and maternal race, age at conception, and 
maternal age were noted. The unadjusted odds of having bacterial vaginosis were 4 times higher 
in African Americans compared to Caucasians (OR=4.0; 95% CI: 1.59-10.37). The odds of 
testing positive for at least one of the following STIs: chlamydia, gonorrhea, and trichomoniasis 
were 3.7 times higher for African-American teens. For every 1 year increase in age at 
conception, the odds of having tested positive for trichomoniasis decreased by 0.51 (OR=0.51; 
95% CI: 0.26-0.95) and the odds of testing positive for gonorrhea decreased by 0.35 (OR=0.35; 
95% CI: 0.16-0.80). Because maternal age and age at conception are highly correlated 
(P<0.0001), similar associations were found between maternal age and testing positive for 
trichomoniasis and gonorrhea (Table 2.3).  
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Table 2.3: Individual Risk Factors Associated with Maternal Infections and Inflammatory 
Conditions in 158 Pregnant Adolescents 
 
Risk Factors Odds Ratio (OR) 
(95% Confidence Interval) 
 
 
Gonorrhea 
Maternal age (years) 
 
0.38 (0.16-0.82) 
 
 
 
Trichomoniasis 
Maternal age (years) 
 
0.51 (0.26-0.92) 
 
 
 
Chorioamnionitis 
Vitamin A <530 RAEa 
 
3.71 (1.10-13.7) 
 
 
 
Recto-vaginal Group B Strep 
Vitamin D intake (mcg/d) 
 
0.87 (0.77-0.98) 
 
 
 
aRAE, retinoic acid equivalent. Logistic regression statistical analyses were performed. 
 
Prior and current history of substance use was reported as follows: 32% (51/158) prior and 
0.6% (1/158) current use of alcohol, 13% (21/158) prior and 11% (17/158) current use of 
cigarettes. In addition, 30% (48/158) and 3.2% (5/158) of teens reported use of marijuana or 
other drugs, respectively, sometime throughout their life. No significant associations were 
evident between drug and alcohol use and any of the outcomes monitored. 
In this study population, approximately 50% of teens reported taking their standard prenatal 
supplements daily across gestation.(20) No significant relationship was observed between 
infection outcomes as a function of supplement use.  
As previously published, the majority (70-90%) of these teens did not meet the EAR for 
several essential micronutrients.(20) No associations were found between macronutrient intake 
or water soluble nutrients and infection outcomes. However, low intake of two fat soluble 
vitamins (A and D) was associated with increased risk for placental chorioamnionitis and recto-
vaginal GBS, respectively (Table 2.3).  
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Table 2.1 displays the distribution of ppBMI in the adolescents based on WHO 
classifications. Compared to underweight and normal weight teens, overweight and obese teens 
had a 3.3 times greater odds of testing positive for BV (OR=3.3; 95% CI: 1.28-9.31). Because of 
this association, additional risk factors for BV were also adjusted for ppBMI and findings 
remained statistically significant. These adjusted odds ratios are presented in Table 2.4.  
 
Table 2.4: Maternal Risk Factors Associated with Selected Infections Across Gestation in 158 
Pregnant Adolescents 
 
Risk Factors Adjusted Odds Ratio (AOR) 
(95% Confidence Interval) 
 
Bacterial Vaginosis 
Maternal Race (African American) 
Maternal ppBMI (kg/m2)a 
 
 4.61 (1.74-13.02) 
1.16 (1.04-1.30) 
 
appBMI, pre-pregnancy body mass index. Odds ratios were obtained using multiple logistic 
regression. 
 
DISCUSSION 
In this group of 158 pregnant adolescents, candida, bacterial vaginosis, recto-vaginal 
GBS, and cystitis were the four most commonly diagnosed infections. Because not all of these 
infections are routinely screened as part of standard obstetrical care and many are asymptomatic, 
our prevalence data likely underestimate the true prevalence of these infections in this pregnant 
adolescent population.  
 Limited data exist on STI prevalence in adolescent pregnant populations. Using the 2003-
2004 NHANES data, we found that the estimated prevalence of STIs in our study population was 
higher than the weighted prevalence reported among sexually-experienced females in the U.S. 
aged 14-19 years for gonorrhea (3% vs. 2.5%), chlamydia (13% vs. 7.1%), and trichomoniasis 
(7.0% vs. 3.6%), but lower for genital herpes (1% vs. 3.4%) and human papillomavirus (HPV) 
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(7.6% vs. 29.5%).(22) The lower prevalence of HPV in these pregnant teens compared to the 
2003-2004 national data is possibly a result of HPV vaccine administration in the U.S. since 
mid-2006 and changes in screening guidelines. In contrast, risk of BV in our study population 
was 25% higher than NHANES data (2001-2004) in which a 29.2% prevalence of BV was 
evident in women 14-49 years old.(12)  
The prevalence of sexually transmitted infections such as chlamydia and gonorrhea is 
known to be higher among teens and young women.(23) Our findings have identified younger 
maternal age as a risk factor for infection with gonorrhea and trichomoniasis. These findings 
differ from national data that found older women (20-24 years) have a higher prevalence than 
adolescent females 15-19 years old,(24) and from NHANES 2003-2004 data that reported a 
significantly higher STI prevalence among 18-19 year old females when compared to 14-15 year 
old adolescent females.(22)  Both of the national comparative data were not focused on pregnant 
adolescent populations. It is possible that disparities in STI prevalence exist between non-
pregnant and pregnant adolescent populations and that the latter group may exhibit higher risk 
sexual behaviors especially at a younger age.  
Finally 26% of teens in our study had a UTI (25% cystitis and 1% had pyelonephritis). 
Women, especially those who are pregnant are at an increased risk for UTIs.(25) Although 
asymptomatic bacteriuria (ASB) in non-pregnant women is relatively benign, ASB along with 
elevated progesterone levels during pregnancy can increase the risk of pyelonephritis.(26), (27) 
While ASB is thought to be present in 2-10% of all pregnant women,(28) prevalence data on 
acute cystitis is limited. Current estimates for symptomatic UTIs are limited but 1-3% of 
pregnant females are believed to have acute cystitis and 0.5-2% have acute pyelonephritis.(29)  
No associations were found between the socioeconomic risk factors assessed and the 
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infection outcomes. Previous research has found that fewer years of education and having 
Medicaid insurance are associated with higher prevalence of BV among non-pregnant 
women.(30) We found no association between health insurance status and outcomes, which may 
be due to limited variability in the types of insurance used as 69% of teens with insurance used 
some form of Medicaid and only 10% reported no insurance. No data on family income was 
obtained which might have provided additional information on socioeconomic status.  
In this study, African-American race was significantly correlated with increased risk of 
BV. A similar association between African-American race and BV was reported in a study of 
298 non-pregnant women receiving care at a county health department site.(30) Using data from 
NHANES III, young adult African Americans have been shown to have a higher prevalence of 
chlamydia, gonorrhea, and trichomoniasis compared to whites.(31) We were unable to find an 
association between race and individual STIs but when these three STIs were combined into one 
category, the odds of testing positive for at least one of the three STIs was 3.7 times higher in 
African American teens. 
Higher maternal ppBMI has been linked to increased risk of several adverse birth 
outcomes.(32) In this teen cohort, higher ppBMI was associated with increased risk BV. In non-
pregnant women and men, obesity has been linked to a variety of infections: UTIs,(33) 
periodontitis,(34) and influenza A (H1N1).(35) Although the exact biological mechanisms 
underlying the observed associations between obesity and infection risk remain unclear, immune 
system dysregulation has been hypothesized.(36)  
In these adolescents 38% had recto-vaginal colonization of GBS a higher prevalence than 
the 25% reported among U.S. pregnant women.(37) We observed an association between low 
maternal dietary vitamin D intake and increased odds of testing positive for recto-vaginal GBS 
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which may be due to the known effects of vitamin D on innate and adaptive immunity(38) and 
the lower vitamin D status found among minority pregnant women(39) and adolescents.(40)  
Poor maternal intake of the vitamin A was associated with an increased risk of 
chorioamnionitis, an inflammation of the placenta due to bacterial infection. Vitamin A is a 
micronutrient widely believed to have anti-inflammatory effects,(41) and our findings with 
chorioamnionitis suggest that vitamin A may also be important in mediating pregnancy-specific 
inflammatory conditions.  
Our retrospective, cross-sectional study had several limitations. We used self-reported 
dietary intake data which is subject to both under- and over-reporting and that may be more 
challenging to recall in an adolescent population. With this study design, we are unable to infer a 
causal relationship for any of the significant associations noted. Furthermore, it is difficult to 
describe the prevalence of these infections as being unique to pregnancy as some infections may 
have been contracted prior to pregnancy. Moreover, in teens diagnosed with multiple infections 
across gestation, it is not always known if the second diagnosis of the infection is a new incident 
infection or simply represents failure to effectively treat the prior infection as not all teens are re-
tested post-treatment. 
To our knowledge, this is the first study to explore risk factors for a wide range of 
diagnosed infections in a pregnant adolescent population receiving age-appropriate care from a 
prenatal adolescent clinic. This group of racially and ethnically diverse pregnant adolescents 
exhibited a higher prevalence of several sexually transmitted and vaginal infections compared to 
data from non-pregnant teen and adult populations. Several risk factors for infections and 
inflammatory conditions across pregnancy were identified including: African-American race, 
higher pre-pregnancy BMI, younger age at diagnosis, and low intake of fat-soluble vitamins A 
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and D. Further research is needed to understand the biological mechanisms which may be 
underlying the observed associations. These data may be useful for clinicians and sexual health 
educators who seek to reduce the infection burden among pregnant adolescents. In addition, 
these results support the need for promoting modifiable dietary and weight gain 
recommendations for improved maternal health.  
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ABSTRACT  
Vitamin D is known to regulate innate and adaptive immune processes at the cellular level, but 
the role of vitamin D status on associated inflammatory processes across pregnancy is unclear. 
Our primary objective was to evaluate relationships between serum biomarkers of inflammation 
(interleukin (IL)-6, interleukin (IL)-10, tumor necrosis factor (TNF)-α, acute-phase proteins (C-
reactive protein and hepcidin) and vitamin D status (25-hydroxyvitamin D (25(OH)D) and 1,25-
dihydroxyvitamin D (1,25(OH)2D)) measured across pregnancy and in the neonate at birth. A 
second objective was to identify associations between vitamin D status and clinically diagnosed 
infections. In this cross-sectional study, 158 racially and ethnically diverse pregnant adolescents 
were recruited from the Rochester Adolescent Maternity Program (RAMP) in Rochester, NY. 
Serum 1,25(OH)2D was significantly lower in adolescents and neonates with IL-6 concentrations 
above the 75th percentile at delivery (P=0.04) and at birth (P=0.004), respectively. After 
adjusting for other potential covariates of inflammation, maternal serum 1,25(OH)2D was 
significantly positively associated with TNF-α during pregnancy (P=0.02), but at delivery 
1,25(OH)2D and TNF-α were inversely associated with one another (P=0.02). Teens who tested 
positive for candida during pregnancy had significantly lower serum 25(OH)D (P=0.04) and 
25(OH)D < 30 ng/ml was associated with bacterial vaginosis (P=0.02). African American 
exhibited significantly lower TNF-α concentrations at both mid-gestation (P=0.05) and delivery 
(P<0.0001) compared to the Caucasian adolescents. These results suggest that lower maternal 
vitamin D status may attenuate inflammatory responses and risk of infection across gestation. 
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INTRODUCTION 
Cytokines are known to play an important role across gestation as they help regulate 
placental implantation, fetal allograft tolerance, and onset of labor.(1) Research conducted over 
the past 30 years suggests that cytokine production during pregnancy is altered in the presence of 
microbial infections.(2) The mother and/or fetus are thought to independently produce pro-
inflammatory cytokines in response to systemic maternal infections and those which have 
reached the intra-amniotic cavity, respectively.(3) Abnormally high cytokine concentrations of 
interleukin (IL)-6 and tumor necrosis factor-alpha (TNF-α) measured in amniotic fluid, the 
amniochorionic membranes, or fetal plasma have been associated with adverse events during 
pregnancy, such as intra-amniotic microbial infection and spontaneous preterm labor in patients 
with premature rupture of membranes (PROM).(4, 5)  
In addition to microbial infections, various demographic, anthropometric, and biological 
factors may influence cytokine concentrations across pregnancy. Older maternal age, higher 
body-mass-index (BMI), and prior pre-term delivery have been associated with higher plasma 
cytokine concentrations among pregnant European women (6) while a longer duration of labor 
has been shown to increase cord C-reactive protein (CRP) in newborns.(7) Active labor has been 
shown to increase maternal hepcidin concentrations,(8) and both cord IL-6 and hepcidin 
concentrations at birth.(9) 
 Calcitriol (1,25(OH)2D) is believed to have a role in maintaining a balance between 
inflammation and immunosuppression.(10) In T helper cells (Th), in vitro studies in cultured 
peripheral blood mononuclear cells (PBMCs) from humans have found 1,25(OH)2D acts to 
inhibit Th1 cell-associated pro-inflammatory cytokines (IL-2, interferon (IFN)-γ, etc.),(11) while 
other cell culture data in mice have found calcitriol to enhance the anti-inflammatory cytokines 
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produced by Th2 cells (IL-4, IL-5, etc.).(12) However, the in vivo action of 1,25(OH)2D on 
cytokine production during unique human physiological states, such as pregnancy, is not well 
understood. 
Due to the established anti-inflammatory activity of 1,25(OH)2D in vitro, it is important 
to understand the vital role vitamin D may play in regulating inflammatory conditions and 
cytokine concentrations across gestation. The present research study was undertaken in a group 
of racially and ethnically diverse pregnant adolescents (≤ 18 years of age) previously shown to 
have both a high burden of infections across gestation (13) and low vitamin D status.(14) The 
primary objective of this research was to determine the relationship between serum biomarkers 
of vitamin D status ((25-hydroxyvitamin D (25(OHD) and 1,25-dihydroxyvitamin D 
(1,25(OH)2D)) and inflammation (IL-10, IL-6, TNF-α, CRP, and hepcidin) measured across 
pregnancy and in umbilical cord blood obtained from the neonate at birth. A second objective 
was to assess possible relationships between vitamin D status and clinically diagnosed infections 
during pregnancy.  
 
MATERIALS AND METHODS 
 Study Population 
Pregnant adolescents (n=158) between 13-18 years of age were enrolled in research 
studies designed to examine changes in maternal and fetal bone health, iron status and infections 
across pregnancy. Adolescents were recruited from the Rochester Adolescent Maternity Program 
(RAMP) in Rochester, New York. Pregnant adolescents were eligible to participate if between 
12 and 30 weeks gestation at entry, carrying a single fetus, and otherwise healthy. At entry into 
the study, self-reported demographics, height, and weight were obtained by a study health project 
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coordinator. Pre-pregnancy body mass index (ppBMI) was calculated and categorized as 
underweight (<18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (≥ 25.0 kg/m2), or 
obese (≥ 30.0 kg/m2) using self-reported height and weight in accordance with the Word Health 
Organization guidelines.(15) Mode of delivery, duration of labor, and neonatal birth data were 
abstracted from medical records. As previously reported, 18 clinically diagnosed infections were 
abstracted from the prenatal medical records by a study health project coordinator.(13) Informed 
written consent, and in those ≤ 14 y adolescent assent and parental consent were obtained. The 
study was approved by the Institutional Review Boards at Cornell University and the University 
of Rochester.  
Biochemical Analyses 
A non-fasting blood sample (10 mL) was collected at mid-gestation (average: 26 ± 3.4 
weeks) (n=155) and upon admission to the hospital for delivery (average: 39.8 ± 1.3 weeks) 
(n=134). In addition, a 10 mL cord blood sample was obtained at delivery (n=128). Variability in 
sample size of biochemical markers analyzed in this study was due to missed sample collections 
or insufficient sample volume. Serum samples were stored at −80°C until analysis. The serum 
vitamin D status biomarker 25(OH)D was measured using a radioimmunoassay (RIA) (Diasorin 
Inc.), intact parathyroid hormone (iPTH) was measured by enzyme-linked immunoabsorbent 
assay (ELISA) (Diagnostic Systems Laboratories), and calcitriol (1,25(OH)2D) was measured by 
Dr. Michael Holick (Boston, MA) using an in-house thymus receptor binding assay. Data on 
biomarkers of vitamin D status and intact parathyroid hormone (iPTH) at mid-gestation, 
delivery, and in cord blood have been published.(14) Serum concentrations of iPTH > 65 pg/mL 
were defined as elevated. In accordance with the 2011 US Institute of Medicine’s report on 
vitamin D and calcium,(16) we categorized 25(OH)D concentrations based on classifications 
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established to maintain adequate bone health: 25(OH)D ≥ 20 ng/ml (“sufficient”) and < 12 ng/ml 
(“at risk of deficiency”). Data were also analyzed using the Endocrine Society’s 25(OH)D cutoff 
for vitamin D sufficiency during pregnancy (25(OH)D ≥ 30 ng/ml).(17) 
Archived maternal serum samples were used to undertake analyses of cytokines (IL-6, 
IL-10, and TNF-α) in serum collected at mid-gestation, delivery, and in cord blood using the 
Magnetic Multiplex MAP kit (Millipore) in the Cornell Human Metabolic Research Unit (Ithaca, 
NY). The limit of detection (LOD) for IL-6, IL-10, and TNF- α was 0.13 pg/ml. The acute phase 
proteins, C-reactive protein (CRP) and hepcidin, were previously measured and reported.(18) 
High sensitivity CRP was analyzed using the Immulite 2000 immunoassay (Siemens), and 
hepcidin was measured by a competitive serum ELISA (Intrinsic Life Sciences). The LOD for 
CRP and hepcidin was 0.2 mg/L, and 2.5 ng/ml respectively. Additionally, the adipokine leptin 
was measured in serum with a commercially available ELISA from Millipore as reported.(14) 
Statistical Analyses 
Concentrations of biomarkers are presented either as the mean ± SD or geometric mean (95% 
confidence interval (CI)), percentage of values above/below the established cut-offs or LOD (if 
applicable), or percentage of elevated values (> 75th percentile) relative to the sample 
population. Undetectable values were included in all analyses and computed as ½ x LOD. 
Differences in mean concentrations of serum biomarkers across gestation were calculated using 
ANOVA with Tukey honest significant difference (HSD) test for multiple comparisons. Simple 
linear regression was used to identify correlations between inflammatory biomarkers. Possible 
determinants of maternal inflammation were explored (maternal vitamin D status, race, ethnicity, 
gestational age, ppBMI, serum leptin, and the presence of a clinically diagnosed infection during 
pregnancy) using linear regression or t-tests. Likewise, potential determinants of neonatal 
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inflammation (neonatal vitamin D status, mode of delivery, duration of labor, serum leptin, 
maternal gestational age, a clinically diagnosed maternal infection during pregnancy, and 
maternal inflammatory biomarker concentrations) were assessed. To determine the most 
significant predictors of inflammation, backwards stepwise regression models were constructed 
using predictors associated with inflammation in bivariate analyses (P<0.10). Natural log (Ln) 
transformations were applied to non-normally distributed variables. Results were considered 
statistically significant at P<0.05. All analyses were performed using JMP 12.0 (SAS Institute).  
 
TABLE 3.1: Subject Characteristics of the 158 Pregnant Adolescents1 
 
Characteristrics Value Range  
Age at enrollment, years (n) 17.1 ± 1.1 (158) 13.6 – 18.7 
Maternal Race, % (n) 
          African American 
          Caucasian 
          Native American 
 
63.3 (158) 
35.4 (158) 
1.3 (158) 
 
Ethnicity, % (n) 
          Hispanic 
          Non-Hispanic 
 
24.7 (158) 
75.3 (158) 
 
GA at prenatal care entry, weeks (n) 10.5 ± 4.7 (137) 2 – 24 
GA at delivery, weeks (n) 39.2 ± 3.0 (154) 21 – 42.1 
Pre-pregnancy BMI, kg/m2 (n) 24.7 ± 5.4 (156) 
 
15.0 – 42.1 
Mode of Delivery 
          C-Section, % (n) 
          Vaginal, % (n) 
 
12 (150) 
88 (150) 
 
Duration of Labor, hours 8.50 ± 5.4 (133) 0.02 – 24.1 
Preterm Birth < 37 weeks, % (n) 9.1 (154)  
Low birthweight < 2500 g, % (n) 3208 ± 2398 (150) 1054 – 4705 
Diagnosed Maternal Infections, % (n)   
          Bacteria Vaginosis  40% (158)  
          Recto-vaginal GBS 38% (158)  
          Candida 
          Chlamydia 
42% (158) 
13% (158) 
 
GA, gestational age; BMI, body-mass-index; GBS, group B streptococcus. 1Values are presented 
as the mean ± SD (n) or % (n). 
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RESULTS 
Subject Characteristics  
Subject characteristics are presented in Table 3.1. Over 60% of the teens self-identified 
as African American and over 30% self-identified as Caucasian which is similar to the U.S. teen 
pregnancy rate which is twice as high for non-Hispanic blacks compared to non-Hispanic white 
teens 15-19 years old (43.9 vs 20.5 per 1,000 females).(19) While receiving age-specific care at 
RAMP, our study cohort had a lower rate of Cesarean (C-section) deliveries compared to U.S. 
data in women < 20 y (12% vs. 22%), and lower rates of preterm birth (< 37 weeks) (9% vs. 
13%), and a lower rate of babies born low birth weight (LBW < 2500 g) (6.7% vs 9.3%) 
compared to U.S. teens 15- 19 years old.(19) These data are consistent with the prenatal care 
provided at midwife-run clinics. 
Relevant clinically diagnosed infections in this cohort are listed in Table 3.1.  
Chorioamnionitis was documented in 14% of the placentas that were sent to pathology (n=45). 
As previously described, the infection burden of this population was more than 25% higher 
compared to non-pregnant and pregnant female adolescents and also compared to adult women 
for chlamydia, bacterial vaginosis (BV), and recto-vaginal group B streptococcus (GBS).(13) 
Racial differences were evident such that African American pregnant adolescents in this cohort 
were more likely to test positive for bacterial vaginosis (BV) or at least one of the following 
STIs: chlamydia, gonorrhea, and trichomoniasis when compared to Caucasian adolescents.(13)  
Biomarkers of Vitamin D and Inflammation 
Similar to data collected in pregnant adolescents (13-18 years old),(14, 20) prevalence of 
25(OH)D < 20 ng/ml was high among the adolescents and neonates studied (47-50%) (Table 
3.2). No significant difference in mean mid-gestation 25(OH)D was noted between ppBMI 
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categories. Additionally, the mean 1,25(OH)2D concentrations remained high (> 100 pg/ml) 
across pregnancy.(14)   
 
TABLE 3.2: Markers of Vitamin D Status and Inflammation in Pregnant Adolescents and Their 
Neonates at Birth 
 
                                 N Mid-gestation N Delivery N Cord 
25(OH)D, ng/ml1 
<12 ng/ml, % (n) 
<20 ng/ml, % (n) 
            <30 ng/ml, % (n) 
155 
 
 
 
20.2 (18.8, 21.8) 
10  
50  
81  
133 18.6 (17.0, 20.5) 
17  
48  
81 
121 18.8 (17.1, 20.5) 
17  
47  
81  
1,25(OH)2D, pg/ml1 100 117 ± 30.3a 96 106 ± 30.6b 74 44.7 (41.3, 48.4)c 
iPTH , pg/ml1 
> 65 pg/ml, % (n) 
 
91 25.0 (22.3, 27.9)a 
3.3  
80 38.4 (33.8, 43.6)b 
18  
33 
 
19.0 ± 12.1c 
0 
IL-10, pg/ml1 
 ≤ 0.13 pg/ml, % 
144 
 
4.57 (3.18, 6.57)a 
17.4  
 
125 9.65 (7.22, 12.9)b 
5.6  
 
96 
 
18.0 (13.6, 24.0)c 
3.1  
 
TNF-α, pg/ml1 
≤ 0.13 pg/ml, %  
 
145 4.48 (3.92, 5.14)a 
0.7  
126 3.54 (3.17, 3.97)b 
0  
 
97 8.31 (7.40, 9.33)c 
0  
 
IL-6, pg/ml1 
≤ 0.13 pg/ml, %  
145 1.02 (0.78, 1.33)a 
15  
 
 
126 3.73 (3.01, 4.63)b 
2.4  
 
97 8.41 (5.99, 11.7)c 
0  
 
CRP, mg/L2 
≤ 2.0 mg/L, %  
113 3.78 (3.10, 4.66)a 
0.9  
4 2.19 (0.06, 79.4) 
25  
86 0.17 (0.13, 0.23)b 
79  
Hepcidin, ng/ml1 
≤ 2.5 ng/ml, % 
145 20.7 (18.0, 23.7)a 
4.8  
129 24.2 (20.2, 29.1)a 
7.8  
120 94.2 (80.4, 110)b 
0 
Leptin, µg/L1 141 22.3 (19.7, 25.2)a 127 29.4 (25.7, 33.6)b 114 7.47 (6.26, 8.91)c 
25(OH)D, 25-hydroxyvitamin D; 1,25(OH)2D, 1,25-dihydroxyvitamin D; iPTH, intact 
parathyroid hormone, IL, interleukin; TNF, tumor necrosis factor; CRP, C-reactive protein. 
1Values are presented as geometric mean (95% CI) except for 1,25(OH)2D (mid-gestation and 
delivery) and iPTH (cord) which are presented as mean ± SD. 2Only 4 subjects had CRP values 
at delivery and these data were excluded from all analyses due to insufficient sample size. Letter 
superscripts indicate statistically significant differences between mean mid-gestation, delivery, 
and cord values (P<0.05).   
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Serum cytokine concentrations at mid-gestation and delivery are displayed in Table 3.2. 
At mid-gestation, IL-6 was significantly positively associated with CRP (r=0.28, n=111, 
P=0.003) (data not shown). At mid-gestation, positive trends were observed between hepcidin 
and the cytokines IL-6 (r=0.16, n=143, P=0.05) and TNF-α (r=0.15, n=143, P =0.08). Elevated 
CRP (> 5 mg/L) at mid-gestation was evident in 42% of the teens, and the mid-gestation 
geometric mean leptin concentration was significantly higher in those with elevated CRP 
concentrations compared to those without (32.7 µg/L, n=43 vs. 17.5 µg/L, n=64, P<0.0001). The 
geometric mean mid-gestation leptin concentration was significantly lower in those with mid-
gestation IL-10 above the 75th percentile compared to those below (17.9 µg/L, n=34 vs. 24.1 
µg/L, n=104, P=0.04). Maternal mid-gestation leptin was significantly positively correlated with 
IL-6 (r=0.18, n=139, P=0.03). At delivery, positive trends between hepcidin and both IL-6 
(r=0.16, n=125, P =0.07) and IL-10 (r=0.17, n=124, P=0.06) were evident with the former 
previously shown to achieve statistical significance in the larger cohort.(18) In addition, a 
positive trend between IL-10 and hepcidin was evident (r=0.17, n=124, P=0.06) at delivery. 
Relationships between maternal and neonatal cytokines were explored. In the neonate, 
geometric mean cytokine concentrations were significantly higher than maternal concentrations 
for IL-6, IL-10, TNF-α and hepcidin, but significantly lower for CRP (Table 3.2). Similar to 
patterns observed in the mother, positive linear correlations between inflammatory biomarkers 
were also evident within the neonate (Table 3.3). In cord blood, IL-6 was significantly positively 
associated with CRP (r=0.29, n=71, P=0.01) (data not shown). No significant associations were 
found between cord leptin and the inflammatory biomarkers in cord blood. Maternal IL-6 during 
pregnancy was significantly inversely associated with umbilical cord IL-10 (r= -0.23, n=88, 
P=0.03). A positive relationship between maternal mid-gestation TNF-α and umbilical cord 
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TNF-α approached significance (r= 0.21, n=89, P=0.05). Significant positive correlations were 
evident between maternal IL-6 at delivery and umbilical cord CRP (r=0.26, n=82, P=0.02). 
Consistent with findings evaluating determinants of iron status in the larger cohort,(9) maternal 
mid-gestation hepcidin was significantly positively correlated with cord hepcidin (r=0.30, n=110, 
P=0.001).  
 
TABLE 3.3: Correlations between Inflammation Biomarkers in Maternal Serum Collected 
during Pregnancy and at Delivery and in Cord Serum Obtained at Birth1 
 
 IL-6 TNF-α Hepcidin 
Pregnancy  
(~26 weeks) 
   
IL-10 r=0.47***  
n=144 
r=0.30*** 
n=144 
 
IL-6  r=0.44*** 
n=145 
 
 
Delivery    
IL-10 r=0.49*** 
n=125 
r=0.20* 
n=125 
 
 
IL-6  r=0.32*** 
n=126 
 
Neonatal Cord    
IL-10 r=0.44*** 
n=96 
r=0.38*** 
n=96 
r=0.22* 
n=95 
IL-6  r=0.29** 
n=97 
r=0.38*** 
n=96 
TNF-α   r=0.37*** 
n=96 
IL, interleukin; TNF, tumor necrosis factor. 1All biomarkers were natural log (Ln) transformed. 
Data presented as Correlation Coefficients (r) and sample size (n). *P<0.05, **P<0.01, 
***P<0.001. 
 
We explored possible relationships between maternal labor or delivery variables and 
neonatal inflammatory biomarkers. Greater mean duration of labor was associated with cord 
hepcidin above the 75th percentile (P =0.01), but not with CRP or any other pro-inflammatory 
cytokine measured. Of the cord inflammatory biomarkers measured, only cord TNF-α was 
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significantly impacted by mode of delivery as evidenced by the significantly higher geometric 
mean concentration of cord TNF-α in neonates born via vaginal delivery compared to C-section 
(P=0.0008).  
 Demographic and Anthropometric Risk Factors  
Of the demographic variables explored (race, ethnicity and gestational age), race was the 
only significant predictor of inflammation. Caucasian teens (n=46) exhibited a 2.75-times higher 
risk of having elevated TNF-α at delivery when compared to African-American teens (n=80) 
[relative risk, RR: 2.75, (95% CI: 1.47, 5.15)]. There was a positive trend between gestational 
age at delivery and the concentration of hepcidin at delivery (P=0.06). At mid-gestation, the 
difference in TNF-α between African American and Caucasian teens approached significance 
(P=0.05). Compared to teens who were underweight or normal weight, teens that were 
overweight or obese prior to pregnancy were at a significantly higher risk for having mid-
gestation IL-6 [RR: 1.75 (95% CI: 1.002, 3.06)] and TNF-α [RR: 1.85 (95% CI: 1.05, 3.27)] 
above the 75th percentile as well as CRP ≥ 5 mg/L [RR: 2.83 (95% CI: 1.79, 4.47)].  
Associations between Infections and Vitamin D 
 Teens with 25(OH)D < 30 ng/ml at mid-gestation (n=72) were significantly more likely 
to have a positive diagnosis of bacterial vaginosis (BV) (P=0.02, n=53). In addition, those who 
tested positive for BV at any point during gestation had significantly higher mean concentrations 
of serum calcitriol at delivery (P=0.007, n=40) while a positive trend between calcitriol and 
infection with BV was evident at mid-gestation (P=0.08, n=41). Because maternal race was 
previously shown to be associated with BV in this cohort,(13) we noted that while controlling for 
maternal race, the associations between positive BV infection and vitamin D status (mid-
gestation 25(OH)D < 30 ng/ml (P=0.06)) and delivery 1,25(OH)2D (P=0.03)) were found to be 
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less significant. Pregnant teens who tested positive for candida compared to those who tested 
negative for candida had significantly lower geometric mean serum 25(OH)D concentrations 
measured at mid-gestation (19.5 ng/ml, n=67 vs. 23.8 ng/ml, n=30, P=0.04) and at delivery (17.2 
ng/ml, n=56 vs. 23.8 ng/ml, n=26, P =0.02).  
Relationships between Infections and Inflammation 
Diagnosis of bacterial vaginosis at any point during pregnancy was associated with a 
significantly higher mid-gestation geometric mean hepcidin concentration (22.1 ng/ml, n=57 vs. 
13.8 ng/ml, n=29, P=0.01). Higher geometric mean maternal IL-6 concentrations at delivery 
were weakly associated with either a diagnosis of chorioamnionitis (4.9 pg/ml, n= 17 vs. 2.2 
pg/ml, n=15, P=0.04) or chlamydia (6.2 pg/ml, n=19 vs. 3.4 pg/ml, n=107, P=0.049). Likewise, 
having a delivery geometric mean hepcidin concentration above the 75th percentile was 
significantly associated with a diagnosis of chorioamnionitis (n=8, P=0.004).  
Significant associations between maternal infections across pregnancy and neonatal 
inflammation at birth were also noted. Neonates whose mother tested positive for chlamydia had 
a 2.8-times higher risk of having cord TNF-α above the 75th percentile [RR: 2.82 (95% CI: 1.49, 
5.35)]. A significantly higher geometric mean cord hepcidin concentration was observed in 
neonates whose mother tested positive for chlamydia at any point during pregnancy (141 ng/ml, 
n=17 vs. 88.1, n=103, P=0.04). The geometric mean IL-10 concentration in neonates whose 
mother tested positive for recto-vaginal group B streptococcus (GBS) was significantly lower 
compared to those testing negative for this infection (12.2 pg/ml, n=41, vs. 24.2 pg/ml, n=53, 
P=0.02). 
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Associations between Inflammation and Vitamin D 
Maternal mid-gestation 25(OH)D was significantly positively associated with delivery 
TNF-α (P=0.02). Teens with mid-gestation 25(OH)D < 12 ng/ml had a significantly higher 
geometric mean hepcidin concentration (31.1 ng/ml, n=16, vs. 19.6 ng/ml, n=129, P=0.04). 
There was a significant positive association between mid-gestation 1,25(OH)2D and mid-
gestation TNF-α (P=0.005, n=100). At mid-gestation, the mean 1,25(OH)2D concentration was 
higher in teens with mid-gestation IL-6 concentrations above the 75th percentile (134 pg/ml, 
n=25 vs. 111 pg/ml, n=75, P=0.001) and mid-gestation CRP concentrations ≥ 5 mg/L (127 
pg/ml, n=34 vs. 111 pg/ml, n=52, P=0.01), respectively. In contrast, at delivery the mean 
1,25(OH)2D concentration at delivery was significantly lower in teens with delivery IL-6 (96.6 
pg/ml, n=26 vs. 111 pg/ml, n=69, P=0.04) and delivery TNF-α (85.6 pg/ml, n=19 vs. 112 pg/ml, 
n=76, P=0.0005) concentrations above the 75th percentile, respectively. Using multivariate 
modeling, a significant interaction effect (P=0.02, n=55) was observed between BV and 
1,25(OH)2D such that the inverse association between 1,25(OH)2D and log IL-6 was only 
significant in those that tested positive for BV. 
In neonates, there was a positive correlation between cord 25(OH)D and TNF-α (P=0.04, 
n=94). Neonates with umbilical cord 25(OH)D < 12 ng/ml had significantly lower geometric 
mean cord hepcidin concentration (58.8 ng/ml, n=19 vs. 105 ng/ml, n=97, P=0.006). The 
1,25(OH)2D umbilical cord geometric mean concentration was significantly lower in those with 
cord IL-6 (37.1 pg/ml, n=16 vs. 49.0 pg/ml, n=50, P=0.004) and hepcidin (38.0 ng/ml, n=20, vs. 
47.5 ng/ml, n=54, P=0.01) above the 75th percentile, respectively.  
Finally, Table 3.4 displays multivariate models used to assess whether vitamin D 
remained a significant predictor of maternal inflammatory biomarkers at mid-gestation, delivery, 
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and in the neonate at birth while controlling for covariates determined to be significant from 
prior bivariate analyses. 
 
TABLE 3.4: Multivariate Models for Selected Inflammation Markers1 
 
Variables P value R2 Adj. β 
Ln Mid-gestation IL-6 
          Ln Mid-gestation Leptin 
          Ln Mid-gestation IL-10 
          Ln Mid-gestation TNF-α 
Ln Mid-gestation TNF-α 
          Mid-gestation 1,25(OH)2D 
          Ln Mid-gestation IL-6 
          Ln Mid-gestation IL-10 
          African American (ref: CA) 
Ln Mid-gestation CRP 
          Mid-gestation 1,25(OH)2D 
          Ln Mid-gestation Leptin 
          Ln ppBMI (kg/m2) 
Ln Delivery TNF-α 
          Delivery 1,25(OH)2D 
          Ln Delivery IL-6 
          African American (ref: CA) 
 
0.005 
<0.0001 
<0.0001 
 
0.02 
0.03 
0.06 
0.009 
 
0.09 
0.003 
0.001 
 
0.02 
0.03 
0.001 
0.33 
 
 
 
0.23 
 
 
 
 
0.37 
 
 
 
0.24 
 
0.428 
0.259 
0.660 
 
0.005 
0.109 
0.068 
-0.365 
 
0.005 
0.454 
1.65 
 
-0.005 
0.113 
-0.405 
Ln Cord Hepcidin 
          Ln Cord 25(OH)D 
          Ln Cord 1,25(OH)2D 
          Ln Mid-gestation Hepcidin 
          Ln Cord IL-6 
 
0.09 
<0.0001 
0.002 
0.02 
0.47 
 
 
0.320 
-1.16 
0.327 
0.123 
Ln, natural log; IL, interleukin; TNF, tumor necrosis factor; 1,25(OH)2D, 1,25-
dihydroxyvitamin D; ref, reference level; CA, Caucasian; CRP, C-reactive protein; 
ppBMI, pre-pregnancy body-mass-index; 25(OH)D, 25-hydroxyvitamin D. 1Bold-face 
indicates statistical significance (P<0.05). 
 
 
DISCUSSION 
In these pregnant adolescents, teens with lower 25(OH)D concentrations were at greater 
risk of infections (candida and bacterial vaginosis) during pregnancy. Adolescents with 
chlamydial infections exhibited increased inflammation at delivery, a finding that was associated 
with decreased calcitriol (1,25(OH)2D). Temporal changes in the associations between vitamin D 
and inflammatory outcomes from mid-gestation to delivery may be a consequence of the 
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dynamic changes in inflammation and calcitriol that occur across gestation. Maternal infection 
with chlamydia was associated with elevated hepcidin and TNF-α in cord blood. Because 
elevated inflammation has been associated with increased risk of adverse birth outcomes, and 
maternal nutritional status may attenuate inflammatory responses across gestation, more 
normative data on maternal vitamin D status and inflammation and its impact on the neonate at 
birth are needed.   
The mean mid-gestation IL-6 concentration observed in this cohort at ~26 weeks of 
gestation was similar to mid-gestation (22-24 weeks) values reported in a Texas study of 28 
pregnant teens (< 18 y) and 438 pregnant adult women (~1.0 pg/ml)(21) whereas mean mid-
gestation TNF-α concentrations in our study population were significantly higher than those 
previously noted in adult pregnant women from Texas (~2 pg/ml).(21) The significant positive 
correlations we observed between IL-6 and TNF-α at mid-gestation are consistent with the 
positive correlations noted at 24 weeks of gestation in a study of over 100,000 pregnant 
European women using a multiplex flow cytometric assay.(6)   
African American teens in our study exhibited significantly lower TNF-α at both mid-
gestation and delivery when compared to the Caucasian adolescents. This finding is supported by 
other reports in the literature that have reported genetic differences in cytokine genes and 
receptors between Caucasian and African Americans. For example, unique single nucleotide 
polymorphisms in TNF-α and its receptor have been reported among Caucasians and African 
Americans for cytokines such as TNF-α and their corresponding receptors.(22, 23) The 
significantly lower soluble TNF-α concentrations in the African American adolescents that we 
observed is also consistent with a previous study of fetal membranes which showed that the 
concentrations of soluble TNF receptors (measured using a multiplex immunoassay) were 
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significantly decreased in culture media from African Americans but increased in culture media 
from Caucasians following in vitro lipopolysaccharide (LPS) stimulation.(24)  
We observed significantly higher mid-gestation IL-6, TNF-α, and CRP concentrations in 
teen mothers with higher ppBMIs. These findings are consistent with the positive correlation 
observed between ppBMI and IL-6 and CRP that we previously reported in the larger cohort.(25) 
Similarly, other studies have demonstrated higher IL-6 in obese individuals,(26) and pregnant 
obese mice,(27) compared to lean control groups. Elevated TNF-α in non-pregnant adults has 
been hypothesized to play a role in obesity-induced insulin resistance.(28, 29) 
In these pregnant adolescents, vitamin D status was independently associated with 
clinical diagnosis of both a bacterial (BV) and a fungal infection (candida). Similar to other 
research findings conducted in pregnant women, we found an inverse association between serum 
25(OH)D at mid-gestation and BV.(30) In contrast, we observed higher serum 1,25(OH)2D at 
mid-gestation and at delivery in those with BV infection. These findings are consistent with 
previously published findings in the larger cohort which noted an inverse association between 
mid-gestation 25(OH)D and delivery 1,25(OH)2D.(14) The inverse relationship between IL-6 
and 1,25(OH)2D evident at delivery appeared to be moderated by the presence of BV infection 
suggesting that the anti-inflammatory role of 1,25(OH)2D during pregnancy may be more 
pronounced in those with infections. In addition, we found that lower maternal 25(OH)D status 
during pregnancy and at delivery was associated with a positive diagnosis of candida infection 
which is consistent with results from a study of hospitalized adults.(31) Our results suggest that 
the immuno-modulatory role of vitamin D may be more evident during states of infection and 
that lower vitamin D status may reduce one’s ability to clear infections during pregnancy. 
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Calcitriol was significantly positively associated with TNF-α during pregnancy but it was 
inversely associated with TNF-α in delivery sera. Prior studies have found inverse associations 
between 1,25(OH)2D and TNF-α in cultured trophoblasts obtained from placentas collected 
during uncomplicated and pre-eclamptic pregnancies.(32, 33) The positive association we 
observed may be due to differential regulation of cytokines at the systemic versue the cellular 
level or possibly due to differences between in vivo conditions and in vitro model systems.  
Temporal changes in 1,25(OH)2D but not 25(OH)D across pregnancy are important to 
take into account when evaluating interactions between vitamin D and cytokines. While 
25(OH)D geometric mean concentrations did not significantly change between pregnancy and 
delivery, mean 1,25(OH)2D decreased by ~ 9% from mid-gestation to delivery. Maternal 
1,25(OH)2D is also dependent on 25(OH)D status, and a vitamin D supplementation study 
conducted in 350 pregnant women found linear relationships between 25(OH)D and 1,25(OH)2D 
up until 25(OH)D concentrations of 40 ng/mL were achieved,(34) a concentration that most 
teens did not achieve in our study. A recent RCT conducted in 57 US pregnant women found that 
2000 IU of vitamin D supplementation was more effective in increasing IL-10+ regulatory CD4+ 
T cells later in pregnancy (36 weeks gestation) than 400 IU of vitamin D.(35) Taken together 
with our findings which demonstrated an inverse association between maternal calcitriol and pro-
inflammatory cytokines IL-6 and TNF-α at delivery, these results suggest that the anti-
inflammatory action of vitamin D may be more critical later in pregnancy.  
Both the pregnant adolescent and her fetus are capable of independently synthesizing 
calcitriol and mounting inflammatory responses, but little is known about how maternal and fetal 
cytokines may interact. Although we did not observe significant correlations between maternal 
and fetal cytokines of the same class, data on the ability of cytokines to cross the placenta are 
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conflicting. A previous study of 19 normal-term placentas found that cytokines TNF-α, IL-1, and 
IL-6 did not cross the placenta ex vivo suggesting that the inflammatory response detected in 
cord blood is of fetal origin.(36) In contrast, an ex vivo study of 10 normal-term placentas found 
that IL-6 was transported across the placenta in a bi-directional manner.(37) The stage of 
gestation may impact findings as data obtaind in a rat model found that maternal IL-6 readily 
crossed the rat placenta at mid-gestation but transfer was reduced by late gestation.(38)  
Chlamydia is a bacterial infection that the neonate is capable of contracting while passing 
through the birth canal at delivery.(39) In neonates studied, maternal infection with chlamydia 
was associated with a significantly increased concentration of TNF-α and hepcidin. A study 
conducted in newborn mice demonstrated that the passive transfer of TNF-α from an immunized 
adult mice to the fetus in utero was associated with a significant decrease in postnatal chlamydial 
colonization of the newborn murine lung.(40) 
Several limitations in our study design were evident. Since no normative data on mean 
serum cytokine concentrations are available and there are no adjustment factors for normalizing 
data to account for variable analytical approaches, we could not directly compare our mean 
cytokine values to those reported in other similar populations. Although we did detect several 
significant associations between maternal biomarkers (inflammation and vitamin D status) and 
infection status, our retrospective study design did not allow us to establish causality.  
 
CONCLUSIONS 
Despite conflicting evidence describing the impact of vitamin D status on inflammation 
during pregnancy, we observed significant inverse associations between 1,25(OH)2D and IL-6 
and TNF-α in the mother at delivery and between 1,25(OH)2D and IL-6 and hepcidin in the 
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neonate at birth. We also demonstrated that the presence of bacterial vaginosis impacted the 
association between IL-6 and 1,25(OH)2D at delivery. Together, our results suggest that 
1,25(OH)2D may influence changes in pro-inflammatory cytokine production during pregnancy 
and infections may moderate these relationships. Given that elevated inflammatory biomarkers 
have been linked to adverse pregnancy outcomes, more research is needed to determine if 
vitamin D supplementation can modify maternal inflammatory responses and promote healthy 
birth outcomes in pregnant populations, particularly those at increased risk of infections and 
vitamin D insufficiency. 
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CHAPTER 4 
 
Vitamin D Mediates the Relationship between Placental Cathelicidin and Group B Streptococcus 
Colonization during Pregnancy 
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ABSTRACT  
Vitamin D is thought to modulate innate immune responses, and recent studies have highlighted 
the autocrine and paracrine functions of vitamin D in the placenta. Our objective was to 
determine the relationship between maternal vitamin D status and placental antimicrobial peptide 
(AMP) expression in a group of racially and ethnically diverse pregnant adolescents. In this 
cross-sectional study, 158 pregnant adolescents were recruited from the Rochester Adolescent 
Maternity Program (RAMP) in Rochester, NY. Maternal serum concentrations of the vitamin D 
biomarkers, 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)2D), were 
measured at mid-gestation (~26 weeks) and at delivery. At the placental level, vitamin D 
regulatory proteins (cubilin, megalin, 1α-hydroxylase (CYP27B1), 24-hydroxylase (CYP24A1), 
vitamin D receptor (VDR)) and AMPs (cathelicidin and hepcidin) were analyzed using 
quantitative PCR and western blot techniques. Placental CYP27B1 mRNA expression was 
significantly positively associated with both placental cathelicidin mRNA expression (P<0.0001) 
and placental hepcidin mRNA expression (P=0.002). In teens with positive recto-vaginal group 
B streptococcus (GBS) colonization, placental mRNA expression of cathelicidin (P=0.007), 
cubilin (P=0.03), and CYP27B1 (P=0.04) were significantly lower compared to those who tested 
negative for this infection. A mediation analysis showed that the indirect relationship between 
GBS colonization and placental cathelicidin mRNA expression was mediated by the placental 
mRNA expression of the vitamin D proteins cubilin and CYP27B1 (P=0.02). Additional research 
is needed to identify the role and relative contributions of placental and systemic vitamin D 
metabolites in relation to potentially pathogenic microorganisms which may be present during 
pregnancy. 
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INTRODUCTION 
Endogenously synthesized antimicrobial peptides (AMPs) are located on mucosal and 
epithelial surfaces of multicellular organisms. In innate immunity, these peptides function to kill 
microorganisms and their activity can be enhanced through synergistic interactions between 
individual peptides (1) and lysozymes.(2) In vivo mouse models have shown increased 
susceptibility to bacterial infection in AMP gene knockout animals.(3)  
Human cathelicidin is a major AMP known to kill a broad range of pathogens, including 
gram-positive and gram-negative bacteria, fungi, and viruses.(4) In addition, hepcidin is a well-
known AMP which functions to limit extracellular microbial growth by preventing the release of 
intracellular iron, the most essential growth-limiting nutrient for potential pathogens.(5, 6) Both 
cathelicidin and hepcidin have been shown to be expressed in the human placenta (7, 8), 
indicating their potential role in mediating maternal infections and preventing pregnancy 
complications. 
 Vitamin D status may regulate AMP production given that vitamin D response elements 
(VDREs) have been identified in the promoter regions of the genes for both cathelicidin and 
hepcidin.(9, 10) Numerous in vitro studies have shown that calcitriol increases the production of 
the antimicrobial peptide cathelicidin by binding to the VDR in macrophages (9, 11) and in vitro 
studies have shown that low serum 25-hydroxyvitamin D (25(OH)D) levels are associated with 
reduced production of cathelicidin by human macrophages in response to Mycobacterium 
tuberculosis.(12)  
To date, potential relationships between maternal vitamin D status, placental expression 
of cathelicidin and hepcidin, and clinically diagnosed infections across gestation are poorly 
described. Therefore, the goal of this study was to 1) elucidate factors associated with placental 
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AMP expression and 2) to evaluate the degree to which vitamin D has an impact on placental 
AMP expression at term in a group of high-risk, pregnant adolescents known to have both a high 
infection burden and suboptimal 25(OH)D status across gestation. 
 
MATERIALS AND METHODS 
Study Population 
Pregnant adolescents (n= 158, ≤ 18 years old) were recruited from the Rochester 
Adolescent Maternity Program (RAMP) in Rochester, New York for two larger prospective 
studies designed to examine changes in maternal and fetal bone health and iron status across 
gestation (Table 4.1). Adolescents between 12 and 30 weeks gestation at entry, carrying a single 
fetus, and otherwise healthy were eligible to participate. Additional eligibility and exclusion 
criteria have been previously reported.(13)  Informed written consent was obtained from all 
participants and in participants 14 y of age and younger, adolescent assent and parental consent 
was also obtained. The study was approved by the Institutional Review Boards at Cornell 
University and the University of Rochester. Data on recto-vaginal GBS were abstracted from the 
participant’s prenatal medical records as previously documented.(14)  
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TABLE 4.1: Subject Characteristics of the 158 Pregnant Adolescents1 
 
Characteristrics Value Range  
Age at enrollment, years (n) 17.1 ± 1.1 (158) 13.6 – 18.7 
Maternal Race, % (n) 
          African American 
          Caucasian 
          Native American 
 
63.3 (158) 
35.4 (158) 
1.3 (158) 
 
Ethnicity, % (n) 
          Hispanic 
          Non-Hispanic 
 
24.7 (158) 
75.3 (158) 
 
GA at prenatal care entry, weeks (n) 10.5 ± 4.7 (137) 2 – 24 
GA at delivery, weeks (n) 39.2 ± 3.0 (154) 21 – 42.1 
Pre-pregnancy BMI, kg/m2 (n) 24.7 ± 5.4 (156) 
 
15.0 – 42.1 
Mode of Delivery 
          C-Section, % (n) 
          Vaginal, % (n) 
 
12 (150) 
88 (150) 
 
Placenta weight, g (n) 606 ± 126  (111) 341 – 979  
Placenta area, in2 (n) 
Preterm Birth < 37 weeks, % (n) 
Mid-gestation 25(OH)D, ng/ml (n) 
Mid-gestation 1,25(OH)2D, pg/ml (n) 
Mid-gestation iPTH, pg/ml (n) 
153 ± 32.7 (75) 
9.1 (154) 
22.4 ± 10.2 (155) 
117 ± 30.3 (100) 
28.7 ± 16.0 
86.4 – 354  
 
5 – 61  
46 – 197  
5 – 97  
1Values are presented as the mean ± SD (n) or % (n); gestational age, GA; body-mass-index, 
BMI; 25-hydroxyvitamin D, 25(OH)D; 1,25-dihydroxyvitamin D, 1,25(OH)2D; intact 
parathyroid hormone, iPTH 
 
 
Serum Biochemical Analyses 
A non-fasting blood sample (10 mL) was obtained at mid-gestation (average: 26 ± 3.4 
weeks) (n=155) and at delivery (average: 39.8 ± 1.3 weeks) (n=134). Variability in sample size 
for the biochemical markers analyzed in this study was due to missed sample collections or 
insufficient sample volume. Serum samples were stored at −80°C until analysis. The serum 
vitamin D status biomarker 25(OH)D was measured using a radioimmunoassay (RIA) (Diasorin 
Inc.), intact parathyroid hormone (iPTH) was measured by enzyme-linked immunoabsorbent 
assay (ELISA) (Diagnostic Systems Laboratories), and calcitriol (1,25(OH)2D) was measured by 
Dr. Michael Holick (Boston, MA) using an in-house thymus receptor binding assay. Data on 
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vitamin D and calcitropic hormones across gestation in this cohort have been published.(13)  
Placental Sample Collection 
Placentas were collected at delivery and representative samples of placental tissue were 
collected as previously described.(15) Representative aliquots of the tissue mixture were placed 
into RNAlater (Ambion) or flash frozen (for western blot analyses). All tissue samples were 
stored at −80°C until analysis.  
Quantitative Real-time PCR (qRT-PCR) 
Placental RNA samples were prepared and quantitative real-time PCR (qRT-PCR) 
analyses performed for CYP27B1 and CYP24A1 as previously described.(16, 17) A subset of 
placental tissue samples (n=86) with quality RNA available was used to conduct new qRT-PCR 
analyses for hepcidin (HAMP), cubilin, megalin, VDR and cathelicidin (CAMP) genes using 
methods as previously detailed.(17, 18) Primers were designed for all targets using the National 
Center for Biotechnology Information (NCBI) sequence identification numbers and 
commercially purchased (IDT) as shown in Table 4.2. A negative reverse-transcriptase (RT) and 
template-free (water) sample was used on all plates. Data were normalized to β-actin. All PCR 
plates also contained a placental tissue control to correct for plate-to-plate variation, and relative 
mRNA expression was analyzed in relation to a control placenta by calculating ΔΔ cycle 
threshold (CT) values.  
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TABLE 4.2: Primer Sequences for Target Genes1 
 
Target NCBI Sequence No. Primer Sequence 
Cathelicidin (CAMP) NM_004345.4 Forward: 5’-TGCGCCTGGTGATGCCT-3’ 
Reverse: 5’-CGAAGCACAGCTTCC -3’ 
Hepcidin (HAMP) NM_021175.3 Forward: 5’-CTGTTTTCCCACAACAGACG-3’ 
Reverse: 5’-TTCGCCTCTGGAACATGG-3’ 
CYP27B1 NM_000785.3 Forward: 5’-CACCCGACACGGAGACCTT-3’ 
Reverse: 5’-TCAACAGCGTGGACACAAACA-3’ 
CYP24A1 NM_000782.4 Forward: 5’-CATCATGGCCATCAAAACAAT-3’ 
Reverse: 5’-GCAGCTCGACTGGAGTGA-3’ 
VDR NM_000376.2 Forward: 5’-ACATCGGCATGATGAAGGA-3’ 
Reverse: 5’-TTCCGCTTCAGGATCATCTC-3’ 
Megalin NM_004525.2 Forward: 5’-TTGTTTTGATGCCTCTGATGA-3’ 
Reverse: 5’-AGCTAGGCATGTTCGCTCAG-3’ 
Cubilin  NM_001081.3 Forward: 5’-CCATGGCATCTGTGAGGATT-3’ 
Reverse: 5’-ACAGACGCAGCTGTACTTGG-3’ 
β-actin NM_001101.3 Forward: 5’-CCAACCGCGAGAAGATGA-3’ 
Reverse: 5’-CCAGAGGCGTACAGGGATAG-3’ 
1National Center for Biotechnology Information, NCBI; vitamin D receptor, VDR. 
 
Western Blotting 
Placental protein lysates were prepared and western blot analyses performed for 
CYP27B1, CYP24A1, and VDR as previously described.(17) For LL-37, protein lysates were 
diluted in a tris-tricine sample buffer (Bio-Rad). Protein samples (37 µg) were boiled and 
separated on a 16.5% tris-tricine pre-cast gel (Biorad) followed by transfer onto Odyssey 
nitrocellulose membranes (Li-Cor). Membranes were blocked in Odyssey tris-buffered saline 
(TBS) blocking buffer (Li-Cor). The primary antibody mixture contained 0.2% Tween (Biorad), 
rabbit (polyclonal) anti-LL-37 (1:1000, Innovagen), and the loading control mouse (monoclonal) 
anti-β-actin (1:10000, Santa Cruz Biotechnology). Membranes were probed using fluorescent 
secondary antibodies (LiCor) and protein bands were quantified using the Odyssey IR imaging 
system (Li-Cor). Similar to other researchers, we detected several bands representing the full 
length pro-peptide (18 kD)(19, 20), partial processing peptide (14 kD, 12 kD, and 10 kD)(21) 
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and the active peptide (~6 kD)(20, 21), respectively (Figure 4.1). A ratio of the active peptide 
(~6 kD) to the full length pro-peptide (18 kD) was used for data analysis purposes as this ratio 
provided more statistically significant results when compared to findings using the active peptide 
or pro-peptide alone. 
 
FIGURE 4.1 
 
 
 
 
 
 
 
FIGURE 4.1: This is a representative western blot of the ladder (lane 1) and a placental study 
sample (lane 2). Bands of interest are less than 20 kD. The un-cleaved, pro-peptide (18 kD), 
partially-processed peptide (14 kD, 12 kD, and10 kD), and active peptide (~6 kD) were detected. 
 
Statistical Analyses 
Simple linear regression was used to examine relationships between placental AMPs 
(cathelicidin mRNA (CAMP), cathelicidin protein (LL-37), and hepcidin mRNA (HAMP)), 
proteins involved in placental vitamin D transport (megalin mRNA, and cubilin mRNA), vitamin 
D hydroxylases (CYP27B1 mRNA, CYP27B1 protein, CYP24A1 mRNA, CYP24A1 protein) 
and the vitamin D receptor (VDR mRNA and VDR protein) with circulating serum markers of 
vitamin D status (25(OH)D and 1,25(OH)2D). A one-way analysis of variance (ANOVA) was 
used to analyze differences in mRNA expression and protein abundance of placental AMPs and 
15 kD 
20 kD 
10 kD 
5 kD 
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placental vitamin D proteins in teens testing positive or negative for recto-vaginal group B 
streptococcus (GBS). Multiple linear regression analysis was used to assess the relationship 
between vitamin D and placental AMPs while controlling for potential covariates (maternal race, 
ethnicity, gestational age at delivery, placental weight, placental area, and mode of delivery). A 
structural equation model (SEM) was used to identify the direct and indirect relationships 
between placental vitamin D proteins, recto-vaginal GBS, and placental antimicrobial peptide 
mRNA expression. Natural log (Ln) transformations were applied to variables which were non-
normally distributed. Results were considered statistically significant at P<0.05. All analyses 
were performed using JMP 12.0 (SAS Institute) and STATA 14. 
 
RESULTS 
Subject Characteristics 
Subject characteristics are presented in Table 4.1. Almost two-thirds of the teens self-
identified as African American and one-quarter self-identified as Hispanic. The infection burden 
in this population was higher than national rates among adolescents for three sexually-
transmitted infections (STIs): gonorrhea, chlamydia and trichomoniasis.(14) Rates were also 
higher compared to national estimates, in pregnant women for recto-vaginal group B 
streptococcus (GBS), and in the general female population for urinary tract infections (UTIs) and 
bacterial vaginosis (BV) as previously described.(14) 
Mean serum concentrations of vitamin D status biomarkers across gestation in this 
population have been reported.(13) Using IOM guidelines, 10% of teens were at risk of vitamin 
D deficiency (25(OH)D < 12 ng/ml). Additionally, approximately 50% of the teens and their 
neonates at birth did not achieve vitamin D sufficiency (25(OH)D > 20 ng/ml).(13) However, 
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using the Endocrine Society’s cutoff for vitamin D sufficiency (25(OH)D > 30 ng/ml), 81% of 
adolescents in our study cohort and their neonates at birth did not achieve vitamin D sufficiency.  
Circulating Vitamin D and Expression of Placental Vitamin D Trafficking Proteins 
The relationships between circulating concentrations of 25(OH)D, 1,25(OH)2D, and 
iPTH and placental vitamin D transport proteins (cubilin and megalin) were explored. Placental 
megalin and cubilin mRNA expression were both significantly inversely associated with 
1,25(OH)2D at delivery (r= -0.32, n=55, P=0.02 and r= -0.34, n=55, P=0.01, respectively). 
However, no significant associations between the maternal concentrations of the vitamin D 
prohormone 25(OH)D or iPTH and placental D transport proteins were evident. 
Vitamin D and Maternal GBS 
Positive diagnosis of GBS colonization (n=29) was associated with significantly lower 
placental CYP27B1 mRNA expression (P=0.04) (Figure 4.2A). In addition, significantly lower 
placental cubilin mRNA expression (P=0.03) was evident in those with positive GBS 
colonization (n=32) compared to those who tested negative. In addition, a negative trend was 
evident between placental VDR protein abundance and positive diagnosis of GBS colonization 
(n=38, P=0.05). 
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FIGURE 4.2 
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N= 48 
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FIGURE 4.2 Positive Diagnosis of recto-vaginal group B streptococcus (GBS) colonization was 
significantly inversely associated with (A) placental CYP27B1 mRNA expression and (B) 
placental cathelicidin (CAMP) mRNA expression. Standard error bars are displayed. 
 
Placental Antimicrobial Peptides (AMPs)  
Significant correlations between placental AMPs were noted. CAMP mRNA was 
significantly positively associated with placental LL-37 protein (r=0.30, n=69, P=0.01) and 
HAMP mRNA (r=0.33, n=86, P=0.002), respectively. The placental mRNA expression of CAMP 
and HAMP as well as the protein abundance of LL-37 did not significantly differ as a function of 
ethnicity, gestational age at delivery, mode of delivery, placental weight, or placental area. 
However, maternal race was a significant predictor of placental cathelicidin. African American 
adolescents had significantly lower CAMP mRNA expression (P=0.03) and LL-37 protein 
abundance (P=0.003) compared to the Caucasian adolescents. After controlling for race, the 
association between CAMP mRNA and LL-37 protein became less significant (P=0.08).  
Placental AMPs and Vitamin D 
Possible associations between placental AMPs and maternal and neonatal vitamin D 
status were explored. A significant positive relationship was evident between CAMP mRNA and 
mid-gestation serum 1,25(OH)2D (r=0.28, n=61, P=0.03) and a positive trend was observed 
between HAMP mRNA and mid-gestation 1,25(OH)2D (r=0.25, n=61, P=0.05). However, no 
significant associations between 1,25(OH)2D and placental AMPs were evident at term. None of 
the other maternal vitamin D metabolites (25(OH)D and iPTH) were found to be significantly 
associated with placental AMPs.  
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At the level of the placenta, placental CYP27B1 mRNA expression was significantly 
positively correlated with the placental mRNA expression of CAMP (P<0.0001) and HAMP 
(P=0.002) (Figures 4.3 A and B). A positive trend was observed between CYP27B1 protein 
abundance and HAMP mRNA expression (r=0.21, n=72, P=0.08). Placental VDR protein 
abundance was significantly inversely associated with CAMP mRNA expression (r= -0.23, n=83, 
P=0.04). CAMP mRNA expression was significantly positively correlated with cubilin mRNA 
expression (r=0.32, n=83, P=0.004). 
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FIGURE 4.3 
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FIGURE 4.3 Placental CYP27B1 mRNA expression is significantly positively associated with 
(A) placental cathelicidin (CAMP) mRNA expression and (B) placental hepcidin (HAMP) 
mRNA expression.  
 
Maternal GBS and Placental AMPs 
Associations between maternal infections and placental AMPs were evident. Recto-
vaginal group B streptococcus (GBS) colonization was present in 38% of the study population. 
Compared to those who tested negative for GBS colonization, adolescents with positive 
diagnosis of GBS colonization showed significantly lower (P=0.007) placental CAMP mRNA 
expression (Figure 4.2B) but no significant associations were evident between GBS colonization 
and HAMP mRNA expression.  
Multivariate Analyses  
CYP27B1 mRNA expression remained significantly positively associated with CAMP 
mRNA expression (P<0.0001) in a model controlling for maternal race, cubilin mRNA, VDR 
protein, mid-gestation 1,25(OH)2D, and GBS colonization. To better assess the significant three-
way associations between placental CAMP mRNA, placental vitamin D (CYP27B1 mRNA and 
cubilin mRNA), and GBS colonization determined in prior analyses, we conducted an additional 
mediation analysis (Figure 4.4). The direct, indirect, and total effects of GBS colonization on 
placental vitamin D expression and both GBS colonization and placental vitamin D on CAMP 
expression are displayed in Table 4.3.  
 
 
 
 
 
 111 
FIGURE 4.4 
 
 
 
 
  
 
 
 
 
      
 
 
FIGURE 4.4 Diagram displaying the structural equation model (SEM) used to determine the 
mediating effect of placental mRNA expression of vitamin D transport protein (cubilin) and 
placental vitamin D metabolism enzyme (CYP27B1) on the association between recto-vaginal 
group B streptococcus (GBS) colonization and placental cathelicidin (CAMP) mRNA 
expression. Individual direct effects are shown above. Statistically significant associations are 
represented by solid black arrows. 
 
 
 
 
 
 
 P=0.05 
Recto-vaginal GBS 
Colonization 
Ln CAMP mRNA 
Ln CYP27B1 mRNA 
Ln Cubilin mRNA 
        P=0.09 
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TABLE 4.3 Mediation Analysis of Placental Vitamin D Expression, Placental Cathelicidin 
Expression, and Recto-vaginal group B streptococcus (GBS) Colonization in 158 Pregnant 
Adolescents1  
 
Proposed Pathway Indirect & 
Direct Effects 
 
Total Effects 
 
Cubilin mRNA  CAMP mRNA (direct) 
Cubilin mRNA CYP27B1 CAMP (indirect) 
β= 0.12, P= 0.16 
β= 0.15, P= 0.046 
β= 0.27, P= 0.02 
GBS Colonization  CYP27B1 mRNA (direct) 
GBS Colonization  Cubilin mRNA CYP27B1 (indirect) 
β= -0.20, P= 0.09 
β= -0.06, P= 0.12 
β= -0.26, P= 0.02 
GBS Colonization  CAMP mRNA (direct) 
GBS Colonization Cubilin + CYP27B1 mRNA  CAMP mRNA (indirect) 
β= -0.14, P= 0.09 
β= -0.20, P= 0.02 
β= -0.34, P= 0.002 
1Table only includes pathways in which an indirect effect was present. Cathelicidin gene, CAMP; group 
B streptococcus, GBS. Bold-face indicates statistical significance.  
 
DISCUSSION 
In this group of 158 pregnant adolescents at risk of vitamin D insufficiency and increased 
infection burden, maternal serum concentration of the hormonally active form of vitamin D 
(1,25(OH)2D) was significantly associated with the mRNA expression of placental vitamin D 
proteins and placental AMPs. In contrast, no significant associations were evident between the 
prohormone 25(OH)D and any of the placental AMPs evaluated. Biological effects of calcitriol 
may be associated with intra-cellular CYP27B1 activity. We found placental CYP27B1 mRNA 
expression to be positively associated with the expression of two antimicrobial peptides, CAMP 
and HAMP. Additionally, lower placental transcript expression of CAMP and CYP27B1 was 
evident in teens testing positive for recto-vaginal group B streptococcus colonization during 
pregnancy. These results suggest that circulating calcitriol and its placental production may play 
an important role in mediating transfer risk of maternal-fetal infections during pregnancy.  
In this pregnant adolescent population, systemic concentrations of maternal 1,25(OH)2D 
measured at delivery were inversely associated with the placental mRNA expression of 25(OH)D 
transport proteins cubilin and megalin. These findings may be further explained by the fact that 
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some studies have shown that vitamin D supplementation leads to higher 25(OH)D and calcitriol 
suggesting that 25(OH)D status constrains 1,25(OH)2D production in pregnancy.(22) In addition, 
mid-gestation 1,25(OH)2D concentrations were previously shown to be significantly positively 
correlated with placental CYP27B1 mRNA expression in this cohort which may suggest a 
greater placental hydroxylation of 25(OH)D into calcitriol in teens with elevated systemic 
calcitriol concentrations.(17) Although maternal serum 25(OH)D concentrations were not 
associated with the mRNA expression of any of the placental proteins measured (cubilin, 
megalin, CYP27B1, CYP24A1, or VDR), we previously found that maternal serum 25(OH)D 
concentrations at mid-gestation and delivery were significantly positively associated with 
placental CYP27B1 protein expression.(17)  
Given the role of 25(OH)D in providing substrate for placental calcitriol production and 
the ability of circulating calcitriol to impact placental gene expression, both of these metabolites 
may play important roles in combatting microbial colonization and survival. In this population of 
pregnant adolescents, recto-vaginal GBS colonization was significantly inversely associated with 
three placental vitamin D targets (cubilin mRNA, VDR protein, and CYP27B1 mRNA). While 
we are not aware of other studies looking at placental expression of vitamin D related proteins in 
relation to GBS, a study in 95 racially-diverse men and women (mean age: 43 years old) reported 
an inverse association between (serum 25(OH)D concentrations < 30 ng/ml) and increased risk 
of tuberculosis infection. In vitro studies conducted using primary human macrophages infected 
with M. tuberculosis also found that addition of 1,25(OH)2D3 to the culture media significantly 
reduced the quantity of living bacteria.(12) Prior findings from our adolescent cohort found that 
teens with lower mid-gestation 25(OH)D status were at greater risk for bacterial vaginosis (BV) 
and that 1,25(OH)2D concentrations at delivery were significantly higher in those with positive 
 114 
bacterial vaginosis infection.(23) While these results suggest that bacterial infections during 
pregnancy are associated with maternal vitamin D status, supplementation studies are needed to 
identify causal associations. 
Little is known about the relationship between maternal GBS and placental antimicrobial 
peptides. Our results found a significantly lower placental mRNA expression of the antimicrobial 
peptide CAMP in those testing positive for recto-vaginal group B streptococcus (GBS) 
colonization compared to those who were negative. These findings may be explained by studies 
demonstrating bacterial modification of AMPs. Bacteria have been shown to exhibit AMP 
resistance via bacterial surface modifications (24), AMP degradation via bacterial proteases (25, 
26), and AMP sequestering.(27, 28) Downregulation of cathelicidin transcript and peptide has 
been demonstrated in epithelial-like human cell lines infected with the bacterium Neisseria 
gonorrhoeae.(29) Furthermore, increased bacterial colonization of the urinary bladder mucosa 
during urinary tract infections has been reported in cathelicidin knockout mice when compared 
to wild type mice.(30) 
Vitamin D may mediate the relationship between GBS during pregnancy and placental 
AMPs. The mediation analysis demonstrated that the indirect effect of GBS on CAMP mRNA 
expression through cubilin and CYP27B1 mRNA expression explained 59% of the total effect. 
In this group of pregnant adolescents, a significant positive relationship between mid-gestation 
serum 1,25(OH)2D and placental CAMP mRNA was evident. Supporting the biological 
plausibility of our results, 1,25(OH)2D has been shown to upregulate CAMP mRNA in a dose-
dependent manner in human monocytes.(12) We observed that placental vitamin D proteins 
(cubilin mRNA and CYP27B1 mRNA) were also significantly positively associated with 
placental CAMP mRNA expression. Similarly, Liu and colleagues showed that monocytes 
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cultured in human serum with CYP27B1 antagonists had an 80% reduction in toll-like receptor 
(TLR) activated CAMP mRNA expression.(12) In a small study carried out in 8 European 
women (median age 62 years old), Hertting and colleagues also found that 12 weeks of daily 
2000 IU vitamin D3 supplementation increased CAMP mRNA expression and protein abundance 
in biopsied urinary bladder tissue infected with E. coli.(31)  
Racial differences in placental CAMP mRNA expression were evident in our study 
population with significantly lower placental CAMP mRNA expression being found among 
African American adolescents compared to Caucasian adolescents. This finding is consistent 
with prior data reporting significantly lower CAMP mRNA concentrations in monocytes cultured 
using serum from African Americans.(12) The authors attributed this finding to the lower 
25(OH)D serum concentrations that are typically found in African Americans compared to 
Caucasians, a finding that we documented in this pregnant adolescent cohort.(12, 13)  
In addition to cathelicidin, the human placenta also expresses the antimicrobial protein 
hepcidin. Placental CYP27B1 mRNA expression was positively associated with the mRNA 
expression of placental antimicrobial HAMP, and a positive trend was evident between mid-
gestation 1,25(OH)2D systemic concentrations and HAMP mRNA. The regulation of hepcidin in 
response to circulating or intracellular vitamin D status is not well understood. In contrast to our 
findings, a study conducted in cultured hepatocytes and monocytes demonstrated reduced 
hepcidin mRNA following treatment with 25(OH)D or 1,25(OH)2D. In addition, the same study 
found a significant reduction in circulating hepcidin concentrations in healthy volunteers (n=7) 
following a single dose of oral 100,000 IU vitamin D2.(10) However, the authors suggested that 
the relationship between vitamin D and hepcidin production may vary depending on the vitamin 
D status of the population studied.(10) Because many of the adolescents in our study were 
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vitamin D insufficient, this may explain why the association between 1,25(OH)2D and hepcidin 
production was positive in this population. 
Additional research on the impact of maternal vitamin D status with intracellular vitamin 
D proteins, intracellular antimicrobial peptides (AMPs), and infections across pregnancy is 
needed to better understand biological factors that may affect pregnancy outcomes. Given the 
role of vitamin D in upregulating CAMP expression, our findings suggest that reduced placental 
vitamin D production may increase susceptibility to infections at the maternal-fetal interface. 
Vitamin D supplementation studies are needed to evaluate the impact of altered vitamin D status 
on pregnancy related infections. These data will be useful in identifying possible benefits of 
maternal vitamin D status on non-calcemic health outcomes. Given that a large percentage of 
preterm births are thought to be mediated by intra-uterine infections, more research is needed to 
identify modifiable factors that are associated with decreased risk of infection over gestation.     
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Key Study Findings and Implications 
 
This doctoral research identified novel findings on risk factors for multiple 
infections in a pregnant adolescent population and described the relationship between 
vitamin D, urogenital infections, and biomarkers of potential immunological relevance 
during pregnancy at both the systemic and placental level. The three specific aims of 
this dissertation were undertaken and discussed in detail in chapters two through four. 
In this final chapter, a brief summary of the major findings will be provided, followed 
by a discussion on the implications of these findings, and suggestions for future 
research. 
In the first specific aim, the prevalence of commonly diagnosed infections in a 
group of pregnant adolescents was determined. Teens (15-19 y), young adults (20-24 
y), and Hispanic and African American minority populations are known to have a high 
burden of sexually-transmitted infections (STIs), but the prevalence of STIs and other 
clinically-relevant infections during adolescent pregnancy had not been widely 
studied. In our pregnant adolescent population, candida (42%), bacterial vaginosis 
(BV) (40%), recto-vaginal group B streptococcus (GBS) colonization (38%), and 
cystitis (25%) were the four most prevalent infections/conditions. The prevalence of 
the latter three infections/conditions in this group of pregnant adolescents was much 
higher than estimates reported among U.S. adult pregnant populations. Compared to 
14-19 year old females in the U.S., the STI burden in our study population was higher 
for chlamydia, gonorrhea, and trichomoniasis.  
Risk factors associated with maternal and placental infections were also 
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identified in the first study aim. Racial differences were evident such that African 
American pregnant adolescents had a higher prevalence of BV and at least one of the 
following STIs: chlamydia, gonorrhea, and trichomoniasis when compared to the 
Caucasians. Younger maternal age was identified as a risk factor for two STIs: 
gonorrhea and trichomoniasis. Although older teens and young adults are known to 
have higher burden of STIs, a possible explanation for the observed results is that 
pregnant adolescents may engage in higher risk sexual behaviors, particularly in 
adolescents that become pregnant when they are 15 y of age or younger. 
Higher pre-pregnancy body-mass-index (BMI) and low intake of fat soluble 
vitamins A and D were associated with increased risk for BV, chorioamnionitis, and 
recto-vaginal GBS, respectively. These findings highlight the importance of 
modifiable risk factors which may reduce infection risk during pregnancy. 
The second research aim was designed to assess correlations between 
circulating vitamin D and inflammatory biomarkers and to determine the relationship 
between vitamin D status and clinically-diagnosed urogenital and placental infections 
during pregnancy. Prior to this research, changes in inflammatory biomarker 
concentrations with respect to vitamin D status across pregnancy had not been well-
studied. The vitamin D prohormone 25(OH)D measured at mid-gestation (~26 weeks) 
was inversely associated with maternal mid-gestation hepcidin concentrations, but 
positively correlated with TNF-α at delivery. During pregnancy, the hormonally active 
vitamin D metabolite, calcitriol, was positively correlated with pro-inflammatory 
biomarkers (TNF-α, IL-6, and CRP) but at delivery, an inverse association between 
calcitriol and TNF-α and IL-6 was found. In the neonate, a positive association 
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between umbilical cord 25(OH)D and TNF-α was evident while an inverse association 
between cord concentrations of calcitriol and pro-inflammatory biomarkers (hepcidin 
and IL-6) was observed. These temporal changes in the significant associations found 
between vitamin D and inflammatory biomarkers highlights the dynamic changes in 
inflammation and calcitriol that occur across gestation and the need to control for 
gestational age when examining study findings. 
The idea that pregnancy is a state of immune suppression has recently been 
criticized as an over-simplification. A strong pro-inflammatory response is required in 
early pregnancy to allow for implantation and placentation, followed by an anti-
inflammatory response, and a return to pro-inflammatory state to promote contraction 
of the cervix during parturition. Because pregnancy is a unique physiological state 
characterized by immune modulation rather than suppression, the relationship between 
vitamin D and inflammation would be expected to vary across gestation as the results 
from our study indicate. 
Given that elevated concentrations of pro-inflammatory cytokines have been 
associated with adverse pregnancy outcomes, such as intra-uterine infections and pre-
term birth (< 37 weeks), it is important to understand the biological factors which may 
contribute to changes in the concentrations of inflammatory biomarkers across 
gestation. As expected, higher concentrations of maternal and fetal pro-inflammatory 
biomarkers were evident in those who had a clinically-diagnosed infection during 
pregnancy. In those testing positive for BV, mid-gestation hepcidin concentrations 
were significantly higher. Maternal chlamydia infection was associated with higher 
IL-6 at delivery and higher cord TNF-α and hepcidin concentrations. Placental 
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chorioamnionitis was associated with increased IL-6 and hepcidin at delivery. 
Together, these data indicate that hepcidin may be an additional biomarker of infection 
during pregnancy and that maternal infections influence fetal inflammatory response. 
Lower 25(OH)D status at mid-gestation was individually associated with 
increased prevalence of two vaginal infections: BV and candida. These results are 
consistent with other studies conducted in pregnant and non-pregnant adult 
populations, respectively. Although these findings suggest that low 25(OH)D 
increases infection risk, an alternative hypothesis proposed by Mangin et al. (122) 
attributes 25(OH)D depletion and the resulting lower circulating concentrations to 
increased intracellular calcitriol production during intra-cellular infections.  
This study produced a novel finding in that the results demonstrated the 
relationship between vitamin D and inflammation could be moderated by the presence 
of an infection. The inverse association observed between calcitriol and TNF-α at 
delivery was only statistically significant in those who had tested positive for BV at 
some point across gestation.  
In the third study aim, several factors associated with the placental expression 
of antimicrobial peptides (AMPs) cathelicidin and hepcidin during pregnancy were 
identified and the impact of vitamin D on AMP expression was determined. In this 
study, African American pregnant adolescents had significantly lower cathelicidin 
mRNA expression and protein abundance compared to Caucasian adolescents. This 
finding is consistent with prior data by Liu et al. reporting significantly lower 
cathelicidin mRNA concentrations in monocytes cultured in serum obtained from 
African Americans (110). Consistent with Liu et al.’s findings, we previously 
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documented that African Americans in our study had lower 25(OH)D concentrations 
which may explain the racial differences in cathelicidin expression. Although no direct 
associations between 25(OH)D and placental AMPs were evident, placental CYP27B1 
mRNA and circulating calcitriol concentrations were positively associated with 
placental cathelicidin and hepcidin mRNA.  
The placental expression of cathelicidin, cubilin, and CYP27B1 as well as the 
protein abundance of the vitamin D receptor (VDR) were lower in pregnant 
adolescents with recto-vaginal GBS colonization. Although, GBS colonization is not 
thought to have any adverse effects on the mother, transfer of this bacterium to the 
neonate can cause a systemic neonatal infection (sepsis). A subsequent mediation 
analysis demonstrated that the relationship between placental cathelicidin expression 
and GBS was mediated by the placental vitamin D proteins CYP27B1 and cubilin. 
Our findings suggest that reduced placental vitamin D production may increase 
susceptibility to infections at the maternal-fetal interface and that vitamin D may be 
important in regulating placental hepcidin transcript expression at term. 
 
Limitations 
There were several limitations in this study which may influence the 
interpretation of these findings. Although we did detect significant associations 
between maternal systemic biomarkers (inflammation and vitamin D status), placental 
biomarkers (AMPs and vitamin D proteins) and infection status, our retrospective 
cross-sectional study design did not allow us to establish causality between vitamin D, 
inflammation, and diagnosed infections. We lacked data on whether the study 
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participants had these infections prior to becoming pregnant as well as if the infection 
was cleared by antibiotic treatment during pregnancy in those that were diagnosed 
with repeat infections. It was also unclear how long the infection had been present 
prior to diagnosis. Data were obtained on systemic cytokine concentrations and site 
specific concentrations of cytokines were not obtained (such as from the cervix as 
prior data have found these site specific concentrations of cytokines to be significantly 
associated with STIs and other vaginal infections). We did not obtain a blood draw 
during early pregnancy (< 12 weeks) which would have allowed us to better 
characterize changes in inflammatory biomarkers across pregnancy in relation to 
vitamin D status. Finally, limitations in sample size may have reduced our ability to 
detect more significant associations. For example, as expected the prevalence of many 
of the STIs in the study population was below 10%. 
 
Future Directions 
Data from this research provides further insight into a unique and under-
studied population: racially and ethnically-diverse pregnant adolescents who are at 
high-risk for vitamin D insufficiency, sexually-transmitted infections, and adverse 
birth outcomes. These findings highlight the need for continued research on the 
intersection between vitamin D, inflammation, and infection risk during pregnancy.  
This research determined that lower vitamin D status during pregnancy was 
associated with an increased prevalence of a bacterial and fungal infection. Despite the 
known impact of CYP27B1 and VDR in the presence of M. tuberculosis, the activity 
of various vitamin D proteins DBP, CY27B1, CYP24A1, and VDR during other 
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infections is unclear. Therefore, scientific research would greatly benefit from further 
studies using animal and cell culture models that are designed to elucidate the 
underlying molecular mechanisms responsible for the potential impact of vitamin D in 
reducing infection risk. Because past studies by Aslan et al. and Han et al. have 
indicated that polymorphisms in VDR are linked to increased infection and disease 
susceptibility (50, 51), additional human studies exploring genetic polymorphisms in 
various vitamin D proteins involved in vitamin D metabolism and function during 
pregnancy are needed. 
Although associations between vitamin D and the placental expression of the 
antimicrobial peptides cathelicidin and hepcidin were identified, additional research 
should be conducted to determine whether this relationship is found for other vitamin 
D-responsive antimicrobial peptides, such as β-defensin-2 during healthy and diseased 
states.  
Because this was an observational study, further insight on variable doses of 
vitamin D and their impact on  the incidence, severity, or re-occurrence of infections is 
needed. Although Zerofsky et al. recently demonstrated that supplementation with 
2000 IU of vitamin D3 at 36 weeks gestation increased the percentage of IL-10+ 
regulatory CD4+ T cells in peripheral blood greater than that observed following 
supplementation with 400 IU of vitamin D3/day (147), the effect of vitamin D 
supplementation on the concentrations of pro-inflammatory and additional anti-
inflammatory biomarkers across gestation is warranted.   
Inadequate vitamin A intake was associated with placental chorioamnionitis in 
this group of pregnant adolescents. Because of the essential role of vitamin A (via 
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RXR) in enabling VDR function, research should be undertaken to determine the 
impact of both of these fat-soluble vitamins, in reducing infection and inflammation 
during pregnancy. 
Finally, further research is needed to understand how culturally- and age-
appropriate educational resources can be developed to reduce the burden of sexually-
transmitted infections among younger, African American adolescents in order to 
improve maternal health and optimize birth outcomes in this pediatric population. 
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